<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26858594</article-id>
<article-id pub-id-type="pmc">4729929</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2015.00510</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Oxytocin and Vasopressin Receptor Gene Polymorphisms: Role in Social and Psychiatric Traits</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Aspé-Sánchez</surname>
<given-names>Mauricio</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/168743/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Moreno</surname>
<given-names>Macarena</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rivera</surname>
<given-names>Maria Ignacia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/258181/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rossi</surname>
<given-names>Alejandra</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/42485/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ewer</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/258184/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Centro Interdisciplinario de Neurociencia de Valparaíso, Universidad de Valparaíso</institution>
<country>Valparaíso, Chile</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Centro de Investigación en Complejidad Social, Facultad de Gobierno, Universidad del Desarrollo</institution>
<country>Santiago, Chile</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Scuola Internazionale Superiore di Studi Avanzati</institution>
<country>Trieste, Italy</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Programa de Doctorado Interdisciplinario de Neurociencias, Facultad de Medicina, Pontificia Universidad Católica de Chile</institution>
<country>Santiago, Chile</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Psychiatry, Harvard Medical School</institution>
<country>Boston, MA, USA</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Marie Prevost, Université Pierre-Mendès-France, France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Anatoly Sorokin, Russian Academy of Sciences, Russia; Litao Sun, The Scripps Research Institute, USA; Hossein Pournajafi-Nazarloo, University of North Carolina, USA</p>
</fn>
<corresp id="fn001">*Correspondence: Mauricio Aspé-Sánchez <email xlink:type="simple">mauricio.aspe.s@gmail.com</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Systems Biology, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>9</volume>
<elocation-id>510</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Aspé-Sánchez, Moreno, Rivera, Rossi and Ewer.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Aspé-Sánchez, Moreno, Rivera, Rossi and Ewer</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Oxytocin (OXT) and arginine-vasopressin (AVP) are two phylogenetically conserved neuropeptides that have been implicated in a wide range of social behaviors. Although a large body of research, ranging from rodents to humans, has reported on the effects of OXT and AVP administration on affiliative and trust behaviors, and has highlighted the genetic contributions of OXT and AVP receptor polymorphisms to both social behaviors and to diseases related to social deficits, the consequences of peptide administration on psychiatric symptoms, and the impact of receptor polymorphisms on receptor function, are still unclear. Despite the exciting advances that these reports have brought to social neuroscience, they remain preliminary and suffer from the problems that are inherent to monogenetic linkage and association studies. As an alternative, some studies are using polygenic approaches, and consider the contributions of other genes and pathways, including those involving DA, 5-HT, and reelin, in addition to OXT and AVP; a handful of report are also using genome-wide association studies. This review summarizes findings on the associations between OXT and AVP receptor polymorphism, social behavior, and psychiatric diseases. In addition, we discuss reports on the interactions of OXT and AVP receptor genes and genes involved in other pathways (such as those of dopamine, serotonin, and reelin), as well as research that has shed some light on the impact of gene polymorphisms on the volume, connectivity, and activation of specific neural structures, differential receptor expression, and plasma levels of the OXT and AVP peptides. We hope that this effort will be helpful for understanding the studies performed so far, and for encouraging the inclusion of other candidate genes not explored to date.</p>
</abstract>
<kwd-group>
<kwd>SNP</kwd>
<kwd>SSR</kwd>
<kwd>psychiatric disorders</kwd>
<kwd>dopamine</kwd>
<kwd>serotonin</kwd>
<kwd>polygenic trait</kwd>
<kwd>quantitative traits loci</kwd>
<kwd>GWAS</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">FONDECYT<named-content content-type="fundref-id">10.13039/501100002850</named-content></funding-source>
<award-id rid="cn001">1141278</award-id>
</award-group>
<award-group>
<funding-source id="cn002">CONICYT<named-content content-type="fundref-id">10.13039/501100002848</named-content></funding-source>
<award-id rid="cn002">SOC-1101</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="137"></ref-count>
<page-count count="18"></page-count>
<word-count count="14864"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Today, the neuropeptides OXT and AVP are, perhaps, the most interesting molecules for social neuroscience (Insel, <xref ref-type="bibr" rid="B63">2010</xref>; Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>; Zink and Meyer-Lindenberg, <xref ref-type="bibr" rid="B137">2012</xref>). They are closely related, phylogenetically conserved nonapeptides, which originated more than 700 million years ago (Macdonald and Macdonald, <xref ref-type="bibr" rid="B88">2010</xref>) and differ in only two aminoacids (Caldwell et al., <xref ref-type="bibr" rid="B18">2008</xref>; Insel, <xref ref-type="bibr" rid="B63">2010</xref>; Macdonald and Macdonald, <xref ref-type="bibr" rid="B88">2010</xref>): whereas the aminoacid sequence of OXT includes an isoleucine and a leucine at the third and eighth position, respectively, AVP has a phenylalalanine and an arginine in the corresponding positions (Figure <xref ref-type="fig" rid="F1">1</xref>). Both peptides contain two cysteine residues that form a disulfide bond, creating a cyclic six aminoacid ring (Caldwell et al., <xref ref-type="bibr" rid="B18">2008</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>OXT and AVP are two closely related nonapeptides that exert their action on central and peripheral targets</bold>. <bold>(A)</bold> OXT and AVP are synthesized in the PVN and the SON of the hypothalamus. The peptidergic neurons in these nuclei project axons to the posterior pituitary, from where the peptides are released into the circulation. They act as hormones on peripheral targets, having well-documented actions (uterine contraction and vasoconstriction, for instance). In addition, dendrites of neurons in the PVN and the SON release the peptides directly into the brain, where they act as neurotransmitters or neuromodulators, regulating complex social cognition and behaviors. <bold>(B)</bold> OXT and AVP differ in only two aminoacids: this schematic drawing shows that, whereas the aminoacid sequence of OXT (top) includes an isoleucine at the third and a leucine at the eighth position, that of AVP (bottom) includes a phenylalanine and an arginine in the corresponding positions. Both peptides contain a cyclic six aminoacid ring, because of the disulfide bond formed by two cysteine residues.</p>
</caption>
<graphic xlink:href="fnins-09-00510-g0001"></graphic>
</fig>
<p>OXT and AVP are synthesized in the somas of two groups of neurons located in the paraventricular and supraoptic nucleus of the hypothalamus (Figure <xref ref-type="fig" rid="F1">1</xref>); they are then transported along axons that project to the posterior pituitary, from where they are ultimately released into the circulation, acting as hormones on peripheral targets (Loup et al., <xref ref-type="bibr" rid="B81">1991</xref>; Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>; Zink and Meyer-Lindenberg, <xref ref-type="bibr" rid="B137">2012</xref>). In addition to their well-documented peripheral actions (e.g., that of OXT in uterine contraction and milk ejection, and of AVP in antidiuresis and vasoconstriction; Loup et al., <xref ref-type="bibr" rid="B81">1991</xref>) they also function within the brain as neuromodulators or neurotransmitters. There they act mainly via dendritic release (Landgraf and Neumann, <xref ref-type="bibr" rid="B76">2004</xref>; Ludwig and Leng, <xref ref-type="bibr" rid="B82">2006</xref>; Leng and Ludwig, <xref ref-type="bibr" rid="B77">2008</xref>; Neumann and Landgraf, <xref ref-type="bibr" rid="B98">2012</xref>; Stoop, <xref ref-type="bibr" rid="B114">2012</xref>) to regulate complex social cognition and behaviors, including attachment (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>; Insel, <xref ref-type="bibr" rid="B63">2010</xref>) and social exploration and recognition (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>). Furthermore, there is a growing body of evidence showing that these neuropeptide signaling pathways are impaired in mental disorders associated with social deficits (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>).</p>
<p>This review summarizes findings on the impact of different OXT and AVP receptor polymorphism on social cognition and behaviors, and on some of the most common mental disorders associated with deficits in social function. Our goal is to put special emphasis on the studies that have shed light on associations involving different receptor polymorphism, even if the functional significance of these polymorphisms is currently unknown. In addition, we highlight the importance of polygenic approaches for the fruitful understanding of the OXT and AVP signaling mechanisms and the studies on the effect of intranasal OXT and AVP infusions on psychiatric disorders.</p>
</sec>
<sec id="s2">
<title>OXT and AVP receptors and their polymorphisms</title>
<p>OXT and AVP receptors (OXTR and AVPR, respectively) belong to the seven transmembrane domain G-protein coupled receptor super-family. Whereas only one form of OXTR is known, three subtypes of AVPR exist, called AVPR1a, AVPR1b, and AVPR2 (Ebstein et al., <xref ref-type="bibr" rid="B40">2012</xref>). The AVPR1a and AVPR1b subtypes are both coupled to G<sub>q</sub>, and signal via phospholipase C. The inositol triphosphate (IP<sub>3</sub>) produced upon receptor activation induces the mobilization of calcium (Ca<sup>2+</sup>) from intracellular reservoirs; it also causes the release of diacylglycerol (DAG), which increases intracellular Ca<sup>2+</sup> and activates protein kinase C (PKC). The rise in intracellular calcium levels activates map kinase (MAPK) and calcium/calmodulin-dependent protein kinase II (CAMKII). In addition, activation of this signaling pathway produces a depolarization that leads to the entry of extracellular Ca<sup>2+</sup> via voltage-gated calcium channels (Thibonnier, <xref ref-type="bibr" rid="B118">1992</xref>; Thibonnier and Schork, <xref ref-type="bibr" rid="B121">1995</xref>; Thibonnier et al., <xref ref-type="bibr" rid="B120">2000</xref>). AVPR1a and AVPR1b are expressed in several tissues and organs, including platelets, the adrenal cortex, kidney, spleen, smooth muscle, endothelium, and adipocytes (Thibonnier, <xref ref-type="bibr" rid="B118">1992</xref>; Thibonnier and Schork, <xref ref-type="bibr" rid="B121">1995</xref>; Thibonnier et al., <xref ref-type="bibr" rid="B120">2000</xref>). In the human brain, they are expressed in the lateral septum, thalamus, basal amygdaloid nucleus, and brainstem (Figure <xref ref-type="fig" rid="F2">2</xref>) but, interestingly, not in the cortex (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B95">2009</xref>). The AVPR2 subtype, on the other hand, is coupled to G<sub>s</sub>, which activates adenylyl cyclase (AC) and causes the production of cAMP and the activation of protein kinase A (PKA). This receptor subtype is expressed on the basolateral membrane of the colleting duct in the medullary portion of the kidney (Thibonnier et al., <xref ref-type="bibr" rid="B120">2000</xref>). The single OXTR, on the other hand, is coupled to G<sub>q</sub>, activating the same intracellular pathway as AVPR1a and AVPR1b. It is expressed in the uterus, the mammary gland, the ovary, lactotroph cells and, in the brain, in the central and basolateral amygdala, medial preoptic area, anterior and ventromedial hypothalamus, olfactory nucleus, vertical limb of the diagonal band of Broca, ventrolateral septum, anterior cingulate, and hypoglossal and solitary nuclei (Figure <xref ref-type="fig" rid="F2">2</xref>; Loup et al., <xref ref-type="bibr" rid="B81">1991</xref>; Boccia et al., <xref ref-type="bibr" rid="B15">2013</xref>). No expression has been reported in the hippocampus (including CA2 and CA3), parietal cortex, raphe nucleus, nucleus ambiguus or pons (Boccia et al., <xref ref-type="bibr" rid="B15">2013</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><bold>OXTR and AVPR are G-protein coupled receptor expressed in key structures of the brain</bold>. Their genes present characteristic polymorphisms associated with differences in human social (and pathological) behaviors. <bold>(A)</bold> In the human brain, OXTR is expressed in the basolateral amygdala, the anterior and ventromedial hypothalamus, the olfactory nucleus, the diagonal band of Broca, the septal nuclei and the anterior cingulate (left). Its gene (right) is located on chromosome 3p25.3 (approximate position indicated by red vertical line). It contains four exons and three introns, which include several known SNPs. <bold>(B)</bold> AVPR1A is expressed in the septal nuclei, the thalamus and the basal amygdaloid nucleus (left); the gene encoding this receptor (right) is located on chromosome 12q14 (approximate position indicated by red vertical line). As in the case for OXTR, it contains an intron before the exon that encodes the seventh transmembrane domain. The schematic includes the SNPs (in the case of OXTR) and SSRs (in the case of AVPR) that are reviewed in this article.</p>
</caption>
<graphic xlink:href="fnins-09-00510-g0002"></graphic>
</fig>
<p>Interestingly, there is some evidence for the formation of heterodimers between AVPR1a, AVPR2, and OXTR (Cottet et al., <xref ref-type="bibr" rid="B28">2010</xref>). Formation of such heteromeric receptors could have important <italic>in vivo</italic> implications, and possibly confound the interpretation of hormonal and neuromodulatory actions (Devost and Zingg, <xref ref-type="bibr" rid="B34">2003</xref>; Cottet et al., <xref ref-type="bibr" rid="B28">2010</xref>). More importantly, despite the highly conserved protein structure of the peptides and of their receptors, it is noteworthy (particularly when extrapolating to humans findings from research done on animals) that their corresponding gene structure and spatial pattern of expression presents species-specific variations, as shown, for instance, in the sequence and brain expression of <italic>AVPR1a</italic> in monogamous vs. non-monogamous vole species (Hammock and Young, <xref ref-type="bibr" rid="B55">2004</xref>, <xref ref-type="bibr" rid="B56">2005</xref>). The variations in gene structure of OXTR and AVPR mostly occur in the form of genetic polymorphisms, which have been proposed to underlie inter- (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>) and intraspecific (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>; Knafo et al., <xref ref-type="bibr" rid="B70">2008</xref>) differences in expression levels (Tansey et al., <xref ref-type="bibr" rid="B117">2011</xref>) and spatial expression patterns (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>; Knafo et al., <xref ref-type="bibr" rid="B70">2008</xref>) in the brain.</p>
<sec>
<title>Types of polymorphisms</title>
<p>A genetic polymorphism is the occurrence of two or more genetic variants for a particular locus in the DNA sequence (i.e., alleles) within a population. Polymorphisms can be classified depending on the types of changes observed in the nucleotide sequence. One of the most common is a change at the level of single nucleotides (single nucleotide polymorphism, SNP). SNP's located in coding regions of the DNA can in turn be classified as nonsynonymous and synonymous, depending on whether or not they alter the amino-acid sequence of the resulting protein, respectively. Finally, a non-synonymous SNP can change the protein's amino-acid sequence (i.e., missense mutation) or result in a truncated protein (i.e., nonsense mutation). SNPs located in noncoding regions can affect the levels of expression and the spatial expression of a gene, and can therefore also alter gene action (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Several SNPs can occur simultaneously at different locations within a given gene and tend to segregate together. Such linked SNPs are called haplotype blocks, or simply haplotypes. The occurrence of these blocks is useful for investigating the genetic bases of common diseases, as it can reduce the number of variants from 500,000 to around 350,000 (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>).</p>
<p>Another common type of polymorphism is microsatellites, or tandem simple sequences repeats (SSRs), which are sequences of about 2–5 bp in length that are repeated, in tandem, between 5 and up to 50 times. In this case, alleles differ in the number of SSR repeats that they contain. Despite the fact that most of the microsatellites in the human genome are located in non-coding regions, and are thus usually considered to be evolutionary neutral, they can nevertheless cause phenotypic differences (Li et al., <xref ref-type="bibr" rid="B80">2004</xref>), including for neurological disorders in humans (Amir et al., <xref ref-type="bibr" rid="B2">1999</xref>).</p>
</sec>
</sec>
<sec id="s3">
<title>Inheritance studies on human behavior</title>
<p>Studies on behavioral genetics have consistently shown that heritability (the proportion of phenotypic variance attributable to genotypic variance) plays a role in determining human complex social traits. According to Plomin et al. (<xref ref-type="bibr" rid="B102">2008</xref>), behaviors can depend on genotype in (at least) three ways: (i) passively, where children inherit from their parents an environment that is correlated with the children's genetic propensities; (ii) evocatively, where children evoke reactions from other people on the basis of their genetic propensities, and (iii) actively, by selecting, modifying, and constructing experiences correlated with their genetic propensities. Thus, a child inheriting a “depressive” allele could also inherit a depressor environment from her depressive parents (passive); act apathetically, making others avoid her (evocative); and develop cognitive biases, viewing the life through gray glasses and creating, in this way, her own depressing reality (active). These genetic influences on environmental measures have been called genotype-environment correlations (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). In addition, there exist genotype-environment interactions, where the effect of environment on some traits depends on the genotype and, conversely, the effect of a given genotype depends on the environment. Phenotypes are, in this way, more than the sum of independent genetic and environmental factors: for instance, variations in socially important behaviors are sensitive to variations in genotypes (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). The early approaches that shed light on the genetic influences on human social behavior, namely the linkage/association studies and the quantitative traits loci (QTL) approach, are described below.</p>
<sec>
<title>Linkage and association studies</title>
<p>In classical linkage studies, heritability is measured on the basis of correlations found among relatives. These studies typically analyze large pedigrees of families presenting a characteristic trait, and, ideally, include monozygotic (MZ) and dizygotic (DZ) twins. Because MZ twins have exactly the same genotype, whereas DZ twins on average share only about 50% of their genetic material, if genetic differences account for phenotypic differences, then MZ twins should exhibit higher correlation than DZ twins in any particular trait (Cesarini et al., <xref ref-type="bibr" rid="B22">2008</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Furthermore, if MZ and DZ twins live in a shared environment, then these correlations are useful for estimating the relative influence of genetic vs. environmental factors on phenotypic variation (Cesarini et al., <xref ref-type="bibr" rid="B22">2008</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). A classical success story of this approach is in the analysis of a five-generation pedigree of a family with members afflicted by Huntington disease, which lead to the identification of the CAG repeat associated with most cases of this disease (Walker, <xref ref-type="bibr" rid="B127">2007</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Alternatively, sib-pair linkage analyses can be carried out, in which case a small number of relatives is considered, but in a large number of families. In both approaches, the researcher is interested in looking for a marker that is co-inherited with the trait of interest: however, these approaches cannot detect associations in which genes have small effects, as is the case for most complex behaviors or disorders (Risch, <xref ref-type="bibr" rid="B108">2000</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). In addition, single-gene disorders tend to be rare, whereas many important multifactorial traits or diseases, including autism, depression, schizophrenia and others affecting human social behavior, occur at much higher frequencies in the population, and also show high heritabilities (Risch, <xref ref-type="bibr" rid="B108">2000</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>).</p>
<p>Association studies, rather than relying on the incidence of a disease (and its associated markers) within families, test whether the frequencies of specific alleles or genotypes differ between groups such as affected individuals vs. controls, or among individuals with extreme scores on a quantitative trait (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). These studies have classically been restricted to a few “candidate” genes (see for instance, Knafo et al., <xref ref-type="bibr" rid="B70">2008</xref>; Rodrigues et al., <xref ref-type="bibr" rid="B109">2009</xref>; Thompson et al., <xref ref-type="bibr" rid="B123">2011</xref>; Luo et al., <xref ref-type="bibr" rid="B83">2015a</xref>,<xref ref-type="bibr" rid="B84">b</xref>). The influence of a given allele is then quantified, for instance, using the odds ratio, which is calculated as the ratio of the frequency of an allele in affected individuals divided by the frequency of this same allele in the control sample. By this measure, an odds ratio of 1.0 means that there is no difference in allele frequencies between affected individuals and controls, whereas odds ratios larger than 3.0 is considered to represent a large effect (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>).</p>
</sec>
<sec>
<title>Pitfalls of linkage and association studies</title>
<p>In any association study, it is critical that the groups be well-matched in terms of ethnicity, gender, and age (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>). If not, the study could identify spurious factors, which are simply due to differences between the groups (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>). For instance, if a disease is more prevalent in one of two ethnically different populations, then any genetic variant that is more common in one of these populations will show an association with a disease simply because of differences in ethnicity. This could be the case for some reports reviewed here, which show inconsistent results but were based on different ethnics groups.</p>
</sec>
<sec>
<title>Quantitative traits loci (QTL)</title>
<p>In a classical monogenic approach, the presence or absence of a trait follows a dichotomous distribution. In the case of qualitative diseases (diseases where the trait is either present or not), a single allele would be necessary and sufficient for the trait to be expressed (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>). Currently, around one thousand single-gene qualitative disorders are known (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). However, when the penetrance is very low, it is virtually impossible to map genes using pedigrees (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>); more importantly, most human social and pathological behaviors are better described as a quantitative and continuous, rather than as a discrete, qualitative variable (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). A polygene (or quantitative gene), on the other hand, is a group of usually pleiotropic genes, which together influence a phenotypic trait, leading to additive, non-epistatic effects (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>). Thus, a quantitative trait is a phenotype that varies in degree and can be attributed to polygenic effects, i.e., the product of two or more genes. Each gene is inherited in a Mendelian fashion, but the additive effect of several genes results in phenotypes that approach a normal distribution within the population (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>). If we include into this model the effects of the environment, then we are dealing with multifactorial traits, where the presence or absence of a trait or disease is influenced by many genetic differences as well as by the environment (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). This approach predicts a continuum of genetic risk, in which diagnosed subjects could be extreme cases that differ quantitatively, but not qualitatively, from normal cases (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>).</p>
</sec>
</sec>
<sec id="s4">
<title>Role of OXTR and AVPR in social behaviors</title>
<sec>
<title>Studies in rodents</title>
<p>Reports implicating OXT and AVP in the control of mammalian social behavior first appeared in the early 90's. For instance, Insel and Shapiro (<xref ref-type="bibr" rid="B64">1992</xref>) showed that the distribution of OXTR in the brain of voles differed between monogamous (prairie) and polygamous (montane) species. Likewise, AVPR distribution also differed between these species, most likely because of differences in promoter structure (SSRs polymorphisms; Young et al., <xref ref-type="bibr" rid="B134">1999</xref>). Most interestingly, intracerebroventricular injections of AVP increased affiliative behaviors in the monogamous prairie vole, but not in the promiscuous montane species (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>), and transgenic mice expressing the prairie vole variant of AVPR also showed increased affiliative behaviors in response to AVP injections (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>). Collectively, these findings suggest that the different pattern of AVPR expression is responsible for the different affiliative behaviors of these two closely related species of voles, as well as for their behavioral responses to AVP.</p>
<p>Since these early studies, a large amount of research has been carried out on these two so-called “prosocial neuropeptides,” most of them using the powerful techniques available in rodent models (Nakajima et al., <xref ref-type="bibr" rid="B97">2014</xref>; Sala et al., <xref ref-type="bibr" rid="B110">2015</xref>; Yan et al., <xref ref-type="bibr" rid="B132">2015</xref>). Regarding OXT, for instance, Nakajima et al. (<xref ref-type="bibr" rid="B97">2014</xref>) demonstrated that blocking neurotransmission from medial prefrontal cortex (mPFC) interneurons that express OXTR (specifically, somatostatin neurons) caused female mice to lose interest in male mice during the sexually receptive phase of the estrous cycle (Nakajima et al., <xref ref-type="bibr" rid="B97">2014</xref>). Similarly, behavioral despair (a behavior associated with depression) was shown to enhance OXT synthesis and secretion in the paraventricular nucleus, supra-optic nucleus, frontal cortex, amygdala, and hippocampus, as well as OXT release from the posterior pituitary into the blood (Yan et al., <xref ref-type="bibr" rid="B132">2015</xref>). Finally, and as a way of example, <italic>OXTR</italic> null mice (<italic>OXTR</italic>
<sup>−∕−</sup>) display increased aggression and autistic-like deficits in social behaviors, such as a resistance to changes in a learned pattern of behavior (comparable to the restricted interest and repetitive behaviors associated with autism; Sala et al., <xref ref-type="bibr" rid="B110">2015</xref>). Furthermore, this study suggests that intracerebral administration of both OXT and AVP reverts the social and learning defects by acting on AVPR1a receptors (Sala et al., <xref ref-type="bibr" rid="B110">2015</xref>). Insights have also been obtained into the possible functionality of some of the <italic>AVPR</italic> alleles, including the impact of SSRs on the pattern of AVPR expression in the brain (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>; Hammock et al., <xref ref-type="bibr" rid="B54">2005</xref>), transcriptional regulation (Hammock and Young, <xref ref-type="bibr" rid="B55">2004</xref>, <xref ref-type="bibr" rid="B56">2005</xref>), and promotor activity (Tansey et al., <xref ref-type="bibr" rid="B117">2011</xref>), all of which are associated with differences in social behaviors, including affiliation (Insel, <xref ref-type="bibr" rid="B63">2010</xref>), aggression (Beery et al., <xref ref-type="bibr" rid="B11">2008</xref>), mating (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>; Caldwell et al., <xref ref-type="bibr" rid="B18">2008</xref>), and anxiety-like behaviors (Hammock et al., <xref ref-type="bibr" rid="B54">2005</xref>; Neumann and Landgraf, <xref ref-type="bibr" rid="B98">2012</xref>).</p>
<p>Regarding psychiatric models, OXT administration has been shown to mimic the effects of antipsychotic drugs. For example, subcutaneous OXT administration in rats reduces prepulse inhibition, a behavioral measure of sensorimotor gating in which a startle response to a stimulus is reduced when it is preceded by a weaker stimulus (Feifel and Reza, <xref ref-type="bibr" rid="B43">1999</xref>; Feifel et al., <xref ref-type="bibr" rid="B44">2012</xref>). These results are relevant since prepulse inhibition is a neurological phenomenon commonly seen in schizophrenic patients (Powell et al., <xref ref-type="bibr" rid="B103">2009</xref>; Ratajczak et al., <xref ref-type="bibr" rid="B106">2013</xref>) thereby suggesting that OXT could produce antipsychotic-like central effects.</p>
<p>Notwithstanding the fact that results from rodents are not easy to extrapolate to primates (for instance, Fink et al. (<xref ref-type="bibr" rid="B45">2006</xref>) found that polymorphisms upstream of <italic>AVPR1a</italic>, which have been associated with differences in social bonding, are evolutionarily distinct between primates and rodents), a substantial body of evidence obtained (initially) through linkage and association studies suggests that <italic>OXTR</italic> and <italic>AVPR</italic> polymorphisms could be part of the genetic sources of the heterogeneity observed in social traits and psychiatric disorders (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>). The next sections describe the structure of the OXTR and AVPR genes and summarize some of the monogenic studies supporting the role of polymorphisms in these genes in human social and pathological behavior.</p>
</sec>
<sec>
<title>Studies in human</title>
<p>In humans, the 17Kb <italic>OXTR</italic> is located on chromosome 3p25.3 and contains four exons and three introns, one of them containing more than twelve known SNPs (Inoue et al., <xref ref-type="bibr" rid="B62">1994</xref>). In the case of AVP, the genes encoding the 3 receptors (<italic>AVPR1a, AVPR1b</italic>, and <italic>AVPR2</italic>) are located on chromosomes 12q14, 1q32, and Xq28, respectively. As is the case for <italic>OXTR</italic>, all contain an intron before the exon that encodes the seventh transmembrane domain (Seibold et al., <xref ref-type="bibr" rid="B112">1992</xref>; Sugimoto et al., <xref ref-type="bibr" rid="B115">1994</xref>; Thibonnier et al., <xref ref-type="bibr" rid="B119">1996</xref>). The majority of polymorphisms studied in OXTR gene are SNPs (Figure <xref ref-type="fig" rid="F2">2</xref>), and some of them appear to be strongly associated with variability in social traits. One of the most studied is rs53576, which consists of a G to A change within the third intron of <italic>OXTR.</italic> In the case of <italic>AVPR1</italic>, the most studied polymorphisms are SSRs, such as RS3 and RS1 (Figure <xref ref-type="fig" rid="F2">2</xref>), the former located upstream of the transcription start site and the latter located in a coding region 553 bp downstream from the start site (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>).</p>
<sec>
<title>Monogenic studies</title>
<p>In this section, we summarize the results from monogenetic studies that have investigated the relationship between polymorphisms in OXTR and AVPR and human social and pathological behaviors. These analyses are summarized in Table <xref ref-type="table" rid="T1">1</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>OXTR and AVPR polymorphisms associated with social and pathological behaviors</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Trait</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Polymorphism studied</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Species/Ethnicity</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Associated Genotype or Haplotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Behavioral phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Brain/Biological phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Interactions with other gene or variable</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Aggression</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1b</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs35369693</td>
<td align="left" colspan="1" rowspan="1" valign="top">147 Europeans, 10 African Canadians, 2 East Asians, and 18 of mixed ethnicity</td>
<td align="left" colspan="1" rowspan="1" valign="top">C allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased aggression</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Haplotypes with rs28676508</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zai et al., <xref ref-type="bibr" rid="B135">2012</xref>; Luppino et al., <xref ref-type="bibr" rid="B85">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">RS1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Irish</td>
<td align="left" colspan="1" rowspan="1" valign="top">Short allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased activity in the left amygdala in a non-clinical sample</td>
<td align="left" colspan="1" rowspan="1" valign="top">Possibly reduced transcription of AVPR1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tansey et al., <xref ref-type="bibr" rid="B117">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">RS1; RS3</td>
<td align="left" colspan="1" rowspan="1" valign="top">94 Caucasian, 7 African-American, 8 Asian-American and 6 Hispanic (17 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">RS3</td>
<td align="left" colspan="1" rowspan="1" valign="top">In linkage disequilibrium in autism (not significant after bonferroni correction)</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kim et al., <xref ref-type="bibr" rid="B69">2002</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">RS1; RS3 and AVR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not specified (<italic>n</italic> = 128 probands, 3 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transmission desequilibrium in autism; Moderate linkage desequilibirum and association with some scores related to autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Haplotypes involving alleles of the three polymorphisms</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yirmiya et al., <xref ref-type="bibr" rid="B133">2006</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2254298 and rs53576</td>
<td align="left" colspan="1" rowspan="1" valign="top">57 Caucasian trios</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2254298 G</td>
<td align="left" colspan="1" rowspan="1" valign="top">Overtransmited in autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phenotypic heterogeneity</td>
<td align="left" colspan="1" rowspan="1" valign="top">Haplotypes with an as yet unidentified susceptibility variant</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jacob et al., <xref ref-type="bibr" rid="B66">2007</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2254298, rs53576, rs237893, rs237894, rs237911, rs237901, rs810568, rs2228485</td>
<td align="left" colspan="1" rowspan="1" valign="top">195 Chinese Han family trios (21 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2254298 A and rs53576 A; haplotypes involving rs53576</td>
<td align="left" colspan="1" rowspan="1" valign="top">Displayed a preferential transmission in Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wu et al., <xref ref-type="bibr" rid="B131">2005</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1b</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2254298, rs53576, rs237893, rs237894, rs237911, rs237901, rs810568, rs2228486</td>
<td align="left" colspan="1" rowspan="1" valign="top">89 Swedish, 89 Belgians in the patients sample (122 females); 88 Swedish and 89 Belgiansin the control sample (117 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G allele for s3 in Swedish sample; G allele for s5 in the Belgian sample; A-T-C-A-G Haplotype in both samples</td>
<td align="left" colspan="1" rowspan="1" valign="top">Recurrent major depression; Overrepresented in controls; Overrepresented in controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ethnicity</td>
<td align="left" colspan="1" rowspan="1" valign="top">Van West et al., <xref ref-type="bibr" rid="B125">2004</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2254298</td>
<td align="left" colspan="1" rowspan="1" valign="top">92 Caucasian adolescent girls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Heterozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Highest levels of symptoms of depression, physical and social anxiety, if they presented history of maternal depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maternal history of recurrent major depressive disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thompson et al., <xref ref-type="bibr" rid="B123">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2254298</td>
<td align="left" colspan="1" rowspan="1" valign="top">Not specified (first cohort composed of 1983 pregnant females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Overrepresented in depressed mothers and families (including fathers)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lower salivary OXT</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Apter-Levy et al., <xref ref-type="bibr" rid="B5">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">413 Caucasian, 18 Asian, 5 Maori/Pacific Islander, 2 Aboriginal and 1 other (261 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">A Carriers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher depressive symptoms if mother has been depressed</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Association between maternal depression in early childhood and youth depressive symptoms in adolescence</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thompson et al., <xref ref-type="bibr" rid="B124">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">167 White, 34 Black, 23 Asian, 17 Arab, 16 South Asian, 6 South East Asian, 4 Latin American, 17 other (213 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Carriers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased depressive symptomatology if suffered childhood maltreatment</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Childhood maltreatment</td>
<td align="left" colspan="1" rowspan="1" valign="top">McQuaid et al., <xref ref-type="bibr" rid="B92">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">128 White female</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Carriers</td>
<td align="left" colspan="1" rowspan="1" valign="top">More emotionally sensitive (lower self-esteem) in response to social ostracism</td>
<td align="left" colspan="1" rowspan="1" valign="top">Altered blood pressure and cortisol levels following rejection for G homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">McQuaid et al., <xref ref-type="bibr" rid="B91">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576; rs2254298</td>
<td align="left" colspan="1" rowspan="1" valign="top">99% Caucasians (71% females; <italic>n</italic> = 268)</td>
<td align="left" colspan="1" rowspan="1" valign="top">No association found</td>
<td align="left" colspan="1" rowspan="1" valign="top">Antidepressant treatment resistance, response or remission</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cyclooxygenase-2 (COX-2), was associated with antidepressant treatment resistance</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mendlewicz et al., <xref ref-type="bibr" rid="B93">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576</td>
<td align="left" colspan="1" rowspan="1" valign="top">43 clinically depressed and 42 healthy female subjects</td>
<td align="left" colspan="1" rowspan="1" valign="top">Exon 1 and 2 methylation patterns</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased methylation state were associated with depression</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulate DNA methylation throughout the whole genome, depending on early environment</td>
<td align="left" colspan="1" rowspan="1" valign="top">Specific genotypes can regulate DNA methylation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B26">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs2268491; rs2254298</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-clinical Chinese subjects (46 males, 55 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">CT higher than CC; CT higher than TT</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cognitive empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gender- dependent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wu et al., <xref ref-type="bibr" rid="B130">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs237887; rs4686302</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non-clinical Chinese subjects (46 males and 55 females).</td>
<td align="left" colspan="1" rowspan="1" valign="top">A Carriers; T carriers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher Emotional empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gender-dependent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wu et al., <xref ref-type="bibr" rid="B130">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">35% Caucasian, 41% Asian, and 24% others. (n =192)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lower levels of dispositional stress reactivity, exhibit greater empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lower heart rate reactivity to a startle anticipation task</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rodrigues et al., <xref ref-type="bibr" rid="B109">2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">No specified (<italic>n</italic> = 1532)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Homozygous; A Homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Greater in-group bias in implicit attitudes; Less motivation to reduce out-group member pain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher ACC and SMA activity; Higher NAc activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Luo et al., <xref ref-type="bibr" rid="B83">2015a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Empathy</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chinese students (<italic>n</italic> = 1536, 710 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Showed a stronger association between empathy and interdependence</td>
<td align="left" colspan="1" rowspan="1" valign="top">Insula, amygdala and superior temporal gyrus</td>
<td align="left" colspan="1" rowspan="1" valign="top">Associated with racial in-group</td>
<td align="left" colspan="1" rowspan="1" valign="top">Luo et al., <xref ref-type="bibr" rid="B84">2015b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Harm avoidance</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chinese Han (<italic>n</italic> = 290, 154 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">A Homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased harm avoidance</td>
<td align="left" colspan="1" rowspan="1" valign="top">Smaller amygdala volumes bilaterally Reduced resting-state functional coupling between the prefrontal cortex and amygdala bilaterally in females</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gender- dependent</td>
<td align="left" colspan="1" rowspan="1" valign="top">Wang et al., <xref ref-type="bibr" rid="B128">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroticism</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chinese Han (<italic>n</italic> = 82, 45 females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Carriers; AA</td>
<td align="left" colspan="1" rowspan="1" valign="top">MPI neuroticism scores correlated with DAT and OXT interaction (AA)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lower striatal DAT availability; Negative correlation between DAT availability and OXT levels in G carriers</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chang et al., <xref ref-type="bibr" rid="B24">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Prosocial Behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">RS1 and RS3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non specified (<italic>n</italic> = 203, 101 females) (<italic>n</italic> = 15 for post mortem studies)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Long (327–343 bp) alleles</td>
<td align="left" colspan="1" rowspan="1" valign="top">Larger allocations in a dictator game and higher scores in self-reported altruism scales</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased mRNA hippocampal levels</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Knafo et al., <xref ref-type="bibr" rid="B70">2008</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Prosocial Behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">108 European - Americans males</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Higher trust behavior</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Krueger et al., <xref ref-type="bibr" rid="B73">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">RS3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Russians (291 patients, 49% females; 302 control group, 59% females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">327 bp allele</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia's negative symptoms; facial affect recognition</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Golimbet et al., <xref ref-type="bibr" rid="B48">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia (Attention)</td>
<td align="left" colspan="1" rowspan="1" valign="top">AVPR1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">RS1; RS3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Non specified (<italic>n</italic> = 113, 75 female)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Long alleles (&gt;325 bp)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Promoter repeat region in partially molding social behavior in both animals and humans</td>
<td align="left" colspan="1" rowspan="1" valign="top">Greater levels of prepulse inhibition</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gender (stronger association in male)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Levin et al., <xref ref-type="bibr" rid="B78">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stress</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">White (74.9%), Black (8.92%), Hispanic (8.92%), and other (52.3% female)</td>
<td align="left" colspan="1" rowspan="1" valign="top">A carriers; G Homozygous</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased Post traumatic symptoms in negative social environment, independently of economic stress; Elevated post traumatic symptoms in negative social environment if economic stress exists</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Economic stress</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thompson et al., <xref ref-type="bibr" rid="B123">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stress</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576 (G/A)</td>
<td align="left" colspan="1" rowspan="1" valign="top">173 European participants, 15 mixed, and 6 “other.” All males</td>
<td align="left" colspan="1" rowspan="1" valign="top">G carriers</td>
<td align="left" colspan="1" rowspan="1" valign="top">Attenuated anticipatory stress response if they received social support</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lower cortisol responses under stress after social support</td>
<td align="left" colspan="1" rowspan="1" valign="top">Social support</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B25">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stress</td>
<td align="left" colspan="1" rowspan="1" valign="top">OXTR; AVPR1a</td>
<td align="left" colspan="1" rowspan="1" valign="top">rs53576; RS1</td>
<td align="left" colspan="1" rowspan="1" valign="top">37% Asian-American, 2% African-American, 23% European-American, 16% Latin American, 7% mixed ethnicity and 15% other. (<italic>n</italic> = 172, 60% females)</td>
<td align="left" colspan="1" rowspan="1" valign="top">G Homozygous; 320 bp</td>
<td align="left" colspan="1" rowspan="1" valign="top">Women with higher poststressor OXT levels reported more positive affect feelings; Men with high levels of poststressor AVP reported more anger and hostility feelings</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gender and poststressor levels of OXT and AVP</td>
<td align="left" colspan="1" rowspan="1" valign="top">Moons et al., <xref ref-type="bibr" rid="B96">2014</xref></td>
</tr>
</tbody>
</table>
</table-wrap>
<sec>
<title>Prosocial behavior</title>
<p>An interesting line of research has shown that humans display several “prosocial” behaviors, including trust, generosity and altruism. These result are of great interest to fields such as Neuroeconomics (Fehr and Camerer, <xref ref-type="bibr" rid="B41">2007</xref>; Ebstein et al., <xref ref-type="bibr" rid="B39">2009</xref>), because the assumption of neoclassical economics is that individuals always act to maximize a utility function which depends exclusively on their own material gain (Fehr and Schmidt, <xref ref-type="bibr" rid="B42">1999</xref>). Because of a growing body of evidence that does not support this hypothesis, this utility function has had to be modified to include other-regarding preferences (Rabin, <xref ref-type="bibr" rid="B104">1993</xref>; Fehr and Schmidt, <xref ref-type="bibr" rid="B42">1999</xref>; Dufwenberg and Kirchsteiger, <xref ref-type="bibr" rid="B37">2004</xref>).</p>
<p>Two independent studies of monozygotic and dizygotic twins, one in Sweden and one in the United States, have shown that there is a significant heritability of prosocial behaviors. Both studies were reported by Cesarini et al. (<xref ref-type="bibr" rid="B22">2008</xref>), who estimated that correlations in trust behavior, as measured in a classical Trust game, are 0.13 and 0.25 in the case of North Americans and Swedish MZ twins, respectively, vs. 0.07 and 0.01 in both populations of DZ twins. The same applies for trustworthiness: MZ were correlated in 0.26 (North Americans) and 0.29 (Swedish), vs. 0.06 (North Americans) and 0.18 (Swedish) for DZ. The heritability estimate is 10% (with a 4–21% confidence interval) for the U.S. study and 20% (with a 3–38% confidence interval) for the Swedish study (Cesarini et al., <xref ref-type="bibr" rid="B22">2008</xref>). Interestingly, unshared environmental variation has a greater impact on phenotypic variation than genetic variation. In another study, the group of Cesarini found that strategies and fundamental economic preference parameters are moderately heritable, with estimates of heritability ranging from 18 to 42% (Cesarini et al., <xref ref-type="bibr" rid="B23">2009</xref>) and, importantly, has suggested that these traits have a polygenic architecture, with the heritable variation being explained by many genes with small effects (Benjamin et al., <xref ref-type="bibr" rid="B13">2012</xref>).</p>
<p>Several association studies are also beginning to shed light on the molecular basis of variations in these so-called “prosocial” behaviors (Kosfeld et al., <xref ref-type="bibr" rid="B71">2005</xref>; Zak et al., <xref ref-type="bibr" rid="B136">2007</xref>; Israel et al., <xref ref-type="bibr" rid="B65">2009</xref>; Ebstein et al., <xref ref-type="bibr" rid="B38">2010</xref>; Krueger et al., <xref ref-type="bibr" rid="B73">2012</xref>; Radke and De Bruijn, <xref ref-type="bibr" rid="B105">2012</xref>). In one of the first reports, Knafo et al. (<xref ref-type="bibr" rid="B70">2008</xref>) classified the <italic>AVPR1a</italic> RS3 SSRs of participants into short (308–325 bp) and long (327–343 bp) versions, and found, using the Dictator game, that subjects with the short version allocated significantly fewer tokens to others than did participants with the long versions. This was confirmed and validated using the family-based association test and two self-report scales (the Bardi-Schwartz Universalism and Benevolence Value-expressive Behavior scales). Interestingly, long <italic>AVPR1a</italic> RS3 repeats were associated with higher levels of hippocampal <italic>AVPR1a</italic> mRNA levels in human <italic>post-mortem</italic> studies, as compared to those measured in individuals bearing the short RS3 repeats (Knafo et al., <xref ref-type="bibr" rid="B70">2008</xref>). Along a similar line, Krueger et al. (<xref ref-type="bibr" rid="B73">2012</xref>) reported that individuals homozygous for the OXTR rs53576 G allele shows higher trust behavior (not just a general increase in trustworthiness or risky behaviors) than do A carriers (i.e., individuals presenting at least one A allele in this SNP; Krueger et al., <xref ref-type="bibr" rid="B73">2012</xref>). Similarly, OXT infusions increase trust (Kosfeld et al., <xref ref-type="bibr" rid="B71">2005</xref>), generosity (Zak et al., <xref ref-type="bibr" rid="B136">2007</xref>), and decrease adherence to social norms (Radke and De Bruijn, <xref ref-type="bibr" rid="B105">2012</xref>).</p>
<p>In addition, <italic>AVPR1b</italic> alleles have been associated with aggression levels in children. Luppino et al. (<xref ref-type="bibr" rid="B85">2014</xref>) reported a significant relationship between the presence of the minor C allele in SNP rs35369693 of <italic>AVPR1b</italic> and teacher-rated reactive aggression (Luppino et al., <xref ref-type="bibr" rid="B85">2014</xref>). Similarly, Zai et al. (<xref ref-type="bibr" rid="B135">2012</xref>) found that this same SNP, as well as haplotypes containing rs35369693 and rs28676508 (both in <italic>AVPR1b</italic>), were also associated with higher child aggression (subjects that scored at or above the 90th percentile on the aggression subscales of both the Child Behavior Checklist and the Teacher's Report Form; Zai et al., <xref ref-type="bibr" rid="B135">2012</xref>).</p>
</sec>
<sec>
<title>Empathy</title>
<p>Empathy is a social behavior defined as a capacity to share and understand the feelings of others (De Vignemont and Singer, <xref ref-type="bibr" rid="B33">2006</xref>). Rodrigues et al. (<xref ref-type="bibr" rid="B109">2009</xref>) reported that subjects homozygous for the G allele of <italic>OXTR</italic> SNP rs53576 exhibit greater empathy compared to A carriers, as measured by the “Reading the Mind in the Eyes” task. Luo et al. (<xref ref-type="bibr" rid="B83">2015a</xref>) compared the behavior and the fMRI responses of individuals when they observed painful or non-painful stimulations of other subjects, who were categorized by racial ingroup/outgroup criteria. They found that individuals that were homozygous for the G variant showed increased activity in the anterior cingulate cortex (ACC) and supplementary motor area (SMA) in response to racial ingroup members' pain, as compared to individuals homozygous for the A variant. By contrast, individuals homozygous for the A allele showed increased activity in structures of the reward system, specifically in the nucleus accumbens, when they watched a racial outgroup member in pain. This opposite response also predicts the participants' attitudes and behavior: the racial ingroup bias in ACC/SMA activity was positively correlated with participants' racial ingroup bias in implicit attitudes (specifically, they made more associations between Asian vs. Caucasian faces and concepts of “good” vs. “bad,” as measured by the Implicit Association Test), whereas nucleus accumbens activity showed a negative correlation with participants' motivations to reduce racial outgroup members' pain.</p>
<p>Noticing the different results obtained between Eastern vs. Western subjects in studies on empathy, this same group also investigated whether the <italic>OXTR</italic> rs53576 SNP interacts with the interdependence trait (i.e., how people view themselves in relation to others) to modulate human empathy. They found a stronger association between interdependence and empathy in G carriers, as compared to A homozygotes (Luo et al., <xref ref-type="bibr" rid="B84">2015b</xref>). In addition, they used fMRI to measure the neural responses elicited by the suffering of others, finding stronger associations between interdependence and empathic neural responses in G/G, as compared to A/A genotypes, in brain structures such as the insula, amygdala, and the superior temporal gyrus Luo et al. (<xref ref-type="bibr" rid="B84">2015b</xref>).</p>
<p>Other studies have investigated the association between other common <italic>OXTR</italic> SNPs and empathy. Emotional empathy is defined as the ability to respond with an appropriate emotion to another's mental states (De Waal, <xref ref-type="bibr" rid="B35">2008</xref>; Shamay-Tsoory et al., <xref ref-type="bibr" rid="B113">2009</xref>). Wu et al. (<xref ref-type="bibr" rid="B130">2012</xref>) found an association between emotional empathy and <italic>OTXR</italic> variation at the rs237887 SNP (with A allele subjects scoring higher than those with the G allele), and the rs4686302 SNP (with T allele subjects scoring higher than those with the C allele). By contrast, cognitive empathy, the capacity to understand another's perspective or mental state (De Waal, <xref ref-type="bibr" rid="B35">2008</xref>), showed associations with SNP polymorphisms rs2268491 (with carriers of the C/T variant scoring higher than those of the C/C) and rs2254298 (with C/T carriers scoring higher than T/T carriers; Wu et al., <xref ref-type="bibr" rid="B130">2012</xref>).</p>
</sec>
<sec>
<title>Autism</title>
<p>Autism is a neurodevelopmental disorder characterized by abnormalities in social relationships, communication deficits, and restricted interests (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>), with a prevalence of 3–6 cases per 10,000 people. Its prevalence is four times higher in males than in females (Freitag, <xref ref-type="bibr" rid="B46">2007</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Although the risk of autism in offspring of autistic parent(s) is small (about 5%; Freitag, <xref ref-type="bibr" rid="B46">2007</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>), it is, nonetheless, 100 times greater than the rate of autism in the general population (Freitag, <xref ref-type="bibr" rid="B46">2007</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>).</p>
<p>A couple of studies have investigated the association between SNPs rs53576, rs2268498, and autism, with rather confusing results. In one of two family-based association tests (FBAT; Horvath et al., <xref ref-type="bibr" rid="B59">2001</xref>), Wu et al. (<xref ref-type="bibr" rid="B131">2005</xref>) found, in a study involving Chinese Han individuals, a significant association between autism and individual variants of <italic>OXTR</italic> SNPs rs53576 and rs2254298, as well as with haplotypes involving rs53576 (specifically, A-A-T-A in rs53576, rs2254298, rs2228485, and rs237911, respectively). By contrast, Jacob et al. (<xref ref-type="bibr" rid="B66">2007</xref>), using Caucasian individuals, found a significant association between autism and polymorphism at the rs2254298 SNP, but not rs53576. Moreover, they found that the overtransmission (i.e., a higher likelihood that the risk allele is transmitted to the affected child, as compared to the non-risk allele) of the G allele was more strongly associated with the autistic disorder group, again in contrast to the study involving Han patients (Wu et al., <xref ref-type="bibr" rid="B131">2005</xref>), which, as noted above, reported the overtransmission of the A allele (Jacob et al., <xref ref-type="bibr" rid="B66">2007</xref>). In addition, there are some reports associating the short alleles of SSR RS1 in <italic>AVPR</italic> with autism: Tansey et al. (<xref ref-type="bibr" rid="B117">2011</xref>), for instance, found that the short alleles of RS1 show a weak association with autism in an Irish population, consistent with a previous study by Kim et al. (<xref ref-type="bibr" rid="B69">2002</xref>).</p>
</sec>
<sec>
<title>Schizophrenia</title>
<p>Schizophrenia is perhaps the most studied disorder of behavioral genetic research in psychopathology (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Its typical symptoms include delusions, hallucinations (especially auditive), disorganization of speech and behavior, and negative symptoms (i.e., loss of normal processes) like flat affect and avolition (Gottesman, <xref ref-type="bibr" rid="B50">1991</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). It is estimated that about 1% of the population is afflicted by the disorder, which presents high heritability (about 48% in identical twins; Gottesman, <xref ref-type="bibr" rid="B50">1991</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Interestingly, although it runs in families, the particular subtype (catatonic, paranoid, disorganized) does not (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>).</p>
<p>There exists a small but significant association between schizophrenia and polymorphisms in the Neuregulin I gene (Lewis et al., <xref ref-type="bibr" rid="B79">2003</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>), which is involved in the development of the nervous system (Harrison and Law, <xref ref-type="bibr" rid="B58">2006</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Although there is currently no evidence of an association between polymorphisms in <italic>OXTR</italic> and <italic>AVPR</italic>, and schizophrenia, there are reports of associations between <italic>OXTR</italic> and <italic>AVPR</italic> polymorphisms and traits associated with the disease, such as attention (the main cognitive domain that is impaired in this disorder; Powell et al., <xref ref-type="bibr" rid="B103">2009</xref>; Ratajczak et al., <xref ref-type="bibr" rid="B106">2013</xref>) and negative symptomatology. Golimbet et al. (<xref ref-type="bibr" rid="B48">2015</xref>) showed that the <italic>AVPR1A</italic> 327bp SSR in RS3 is associated with negative symptoms (as measured using the Positive and Negative Symptoms Scale, PNSS), and tended to be linked with patient facial affect recognition, probably impacting social phenotypes of schizophrenia. In addition, Levin et al. (<xref ref-type="bibr" rid="B78">2015</xref>) used a robust family-based strategy to show that longer RS3 alleles were associated with greater levels of prepulse inhibition, a classical paradigm designed to measure attention. This association was stronger in males.</p>
</sec>
<sec>
<title>Depression</title>
<p>Depression is a state of low mood and aversion to activity, with characteristic symptoms including anhedonia, overeating or loss of appetite, insomnia, excessive sleep, fatigue, aches, pains, digestive problems, and reduced energy (McGuffin et al., <xref ref-type="bibr" rid="B90">2003</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). Subjects suffering severe depression may contemplate, attempt to, or commit suicide (McGuffin and Katz, <xref ref-type="bibr" rid="B89">1989</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>), emphasizing its societal importance. The familial risk of major depression and of bipolar disorder is about 9%, as compared to 3 and 1% in control samples for depression and bipolar disorder, respectively (McGuffin et al., <xref ref-type="bibr" rid="B90">2003</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>).</p>
<p>Some reports have shown heritability of depression-protective alleles and depression-related traits. Consistent with an interpersonal perspective on depression (Joiner and Coyne, <xref ref-type="bibr" rid="B67">1999</xref>), Apter-Levy et al. (<xref ref-type="bibr" rid="B5">2013</xref>) found that, in the families of depressed mothers, salivary OXT levels was lower in mothers, children and also in fathers, as compared to control families. Children, in addition, had lower empathy and social engagement levels, and 61% of the children displayed axis I disorders, mainly anxiety and oppositional defiant disorder, compared to 15% of children of nondepressed mothers. The <italic>OXTR</italic> rs2254298 SNP homozygous for the G variant was overrepresented in depressed mothers and their families (including fathers), and correlated with lower salivary OXT. The presence of a single A allele in this SNP in depressed mothers markedly decreased the risk psychopathology in the child (Apter-Levy et al., <xref ref-type="bibr" rid="B5">2013</xref>).</p>
<p>Another study found that youth possessing at least one A allele of the <italic>OXTR</italic> rs53576 SNP, whose mothers had had a history of depression (as measured at age 15, using the SCID-I scale), exhibited the highest levels of depressive symptoms at age 15 (as measured by the Beck Depression Inventory II; BDI-II), showing that SNP rs53576 acts as a moderator variable in the transmission of maternal depression from mothers to their children (Thompson et al., <xref ref-type="bibr" rid="B124">2014</xref>). In addition, under high levels of childhood maltreatment (as reported by the Childhood Maltreatment Questionnaire) only carriers of the G allele of SNP rs53576 presented increased depressive symptomatology (as measured by BDI) when compared to those with the A/A genotype (McQuaid et al., <xref ref-type="bibr" rid="B92">2013</xref>). Moreover, carriers of the G allele were more emotionally sensitive (lower self-esteem) in response to social ostracism (measured by the Social Ostracism and Mood Scale), and showed altered blood pressure and cortisol levels following social rejection induced by the Cyberball task, a well-established computerized game used to induce feelings of social rejection (Williams et al., <xref ref-type="bibr" rid="B129">2000</xref>; McQuaid et al., <xref ref-type="bibr" rid="B91">2015</xref>).</p>
<p>There are also reports on the putative role of polymorphisms in AVPR genes and mood disorder spectrum (Dempster et al., <xref ref-type="bibr" rid="B32">2007</xref>). In a Swedish and a Belgian study, for instance, the haplotype defined by alleles A-T-C-A-G for the <italic>AVPR1b</italic> SNPs s1-s2-s3-s4-s5 was significantly over-represented in controls vs. patients with depression (Van West et al., <xref ref-type="bibr" rid="B125">2004</xref>). Despite these associations, there are reports that, at least for <italic>OXTR</italic>, polymorphisms do not alter antidepressant treatment resistance, response or remission, nor are they associated with variations in the inflammatory pathways that have been reported to play a role in antidepressant efficacy, such as cyclooxygenase-2 and <italic>OXTR</italic> SNPs rs53576 and rs2254298 (Mendlewicz et al., <xref ref-type="bibr" rid="B93">2012</xref>).</p>
</sec>
<sec>
<title>Stress</title>
<p>Thompson et al. (<xref ref-type="bibr" rid="B123">2011</xref>) found, in a sample of Caucasian girls, that subjects who were heterozygous for the <italic>OXTR</italic> rs2254298 polymorphism (presenting A–G substitutions), and had high early life adversity, showed the highest levels of depression and of physical and social anxiety. Another study showed influences of the rs53576 SNP on stress: Thompson and Holman (<xref ref-type="bibr" rid="B122">2013</xref>), for instance, found that individuals homozygous for the rs53576 G allele that had been exposed to a history of negative social environment (specifically had been suffering high economic stress, measured using a Likert scale created for the study) showed elevated post-traumatic stress symptoms after the 9/11 events in the United States, as measured using the post-traumatic stress disorder (PTSD) Checklist. The same risky G allele was associated with lower cortisol responses to stress after social support, compared to similarly challenged individuals of the same genotype, but receiving no social support (Chen et al., <xref ref-type="bibr" rid="B25">2011</xref>). In addition, this G allele and the <italic>AVPR</italic> 320 bp RS1 SSR seem to have a gender specific interaction with cortisol plasmatic levels, where women, but not men, with high levels of poststressor OXT and the G/G genotype, felt the most positive affect after the stressor; by contrast, only men with high levels of poststressor AVP and the 320 allele of the RS1 polymorphism reported more poststressor anger than noncarriers (Moons et al., <xref ref-type="bibr" rid="B96">2014</xref>).</p>
</sec>
<sec>
<title>Harm avoidance</title>
<p>In females, the A/A genotype in rs53576 is associated with an increase in harm avoidance. In addition, females with this genotype presented significantly smaller amygdalar volumes, bilaterally, especially its centromedial subregion. In addition, the A/A allele is associated with reduced resting-state functional bilateral coupling between the prefrontal cortex and amygdala: in the left hemisphere this coupling was positively correlated with harm avoidance scores in female subjects (Wang et al., <xref ref-type="bibr" rid="B128">2014</xref>).</p>
</sec>
<sec>
<title>Neuroticism</title>
<p>Carriers of the G variant of rs53576 showed lower striatal DAT availability and a negative correlation between DAT availability and OXT levels (Chang et al., <xref ref-type="bibr" rid="B24">2014</xref>). Furthermore, the OXT × DAT interaction was significantly correlated with the MPI neuroticism score in the A/A group (Chang et al., <xref ref-type="bibr" rid="B24">2014</xref>).</p>
</sec>
</sec>
<sec>
<title>Polygenic approach</title>
<p>Do <italic>OXTR</italic> and <italic>AVPR</italic> signaling pathways interact with other transmitter systems (Sauer et al., <xref ref-type="bibr" rid="B111">2013</xref>)? This question has recently been approached in studies involving both a couple of well-known <italic>OXTR</italic> SNPs and <italic>AVPR</italic> SSRs, and polymorphisms in genes from pathways known to interact with these neuropeptide systems. A difficulty of this approach is that, mainly because of pleiotropy, we often do not have a strong hypothesis regarding which are relevant candidate genes and gene pathways to consider (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). For such cases, an increasingly popular alternative is the genome-wide association studies (GWAS), which use a dense map of markers to genotype the entire genome. This requires scanning about 500,000 SNPs or, if selecting wisely based on haplotype blocks, about 350,000 SNPs (Cardon and Abecasis, <xref ref-type="bibr" rid="B20">2003</xref>; Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>); for these purposes, a valuable complement is to use microarrays (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). However, given the limited accessibility to GWAS (mainly due to their cost), and the lack of microarray chips containing the <italic>OXTR</italic> and <italic>AVPR</italic> markers reviewed here [for instance, the <italic>OXTR</italic> SNP rs53576 is not present on many chips currently available for autism spectrum disorders (ASD); Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>], selecting a couple of candidate genes and studying their interactions via polygenic association studies remains a valuable approach. In any event, there are only a few reports that have used a candidate gene polygenic approach or GWAS to investigate the effects (and functionality) of polymorphisms in <italic>OXTR</italic> and <italic>AVPR</italic> on social and pathological behaviors. These few (selected) studies are discussed below.</p>
<sec>
<title>Autism</title>
<p>Nyffeler et al. (<xref ref-type="bibr" rid="B99">2014</xref>) found, in a Caucasian population, that a significant part of the risk for high functioning autism is explained by the combination of four polymorphisms: HTTLPR (a polymorphic repeat inside the gene coding for the serotonin transporter), SNP rs6311 in <italic>HTR2A</italic> (which encodes the serotonin receptor 5-HT2A), and the rs2254298 and rs53576 SNPs in the <italic>OXTR</italic>. These data provide evidence supporting a polygenic inheritance of ASD, involving both the OXT and the 5-HT pathways (Nyffeler et al., <xref ref-type="bibr" rid="B99">2014</xref>). Kelemenova et al. (<xref ref-type="bibr" rid="B68">2010</xref>), using a sample of autistic boys in Slovakia, also focused their research on several candidate gene polymorphisms associated with autism, specifically <italic>OXT</italic> (rs2740204), <italic>OXTR</italic> (rs2228485), <italic>GABA receptor gamma 3</italic> (rs28431127), <italic>neuroligin</italic> (rs5916338), and <italic>reelin</italic>. The authors found only one significant association: between autism and a higher number of GGC repeats in the (GGC)n STR polymorphism of the reelin gene, in addition to finding lower reelin levels in the blood and the brain of autistic patients.</p>
</sec>
<sec>
<title>Emotional withdrawal</title>
<p>Haram et al. (<xref ref-type="bibr" rid="B57">2015</xref>) performed an association analysis between polymorphisms at four OXT pathway genes (<italic>OXT, OXTR, AVP</italic>, and <italic>CD38</italic>) and four areas of social psychopathology (as measured by Positive and Negative Syndrome Scale), finding an association between the A allele in the rs53576 SNP and the Emotional Withdrawal traits. However, they did not find an association between any of the genes included in the analysis and a diagnosis of psychotic disorder.</p>
</sec>
<sec>
<title>Oppositional-defiant disorder</title>
<p>In a GWAS performed in a clinical sample of children and adolescents, Aebi et al. (<xref ref-type="bibr" rid="B1">2015</xref>) failed to find an association between oppositional-defiant disorder and the polymorphisms DRD4 exon3 VNTR (located in exon 3 of the D4 dopamine receptor gene), HTTLPR, and seven <italic>OXTR</italic> SNPs. They also performed a GWAS including oppositional-defiant disorder dimensions. Controlling for factors such as age, sex, and parental abilities, the authors did not find an association between any of the variables (Aebi et al., <xref ref-type="bibr" rid="B1">2015</xref>).</p>
</sec>
</sec>
<sec>
<title>What do we know about the functional consequences of these polymorphisms?</title>
<sec>
<title>Amygdala volume</title>
<p>For <italic>OXTR</italic> rs2254298, participants homozygous for the G allele were found to have smaller volumes of both left and right amygdala, posterior brain stem and dorsomedial anterior cingulate cortex, as compared to carriers of the A allele (Furman et al., <xref ref-type="bibr" rid="B47">2011</xref>). In this same SNP, the A allele was positively correlated with bilateral amygdala volume: the larger the number of rs2254298 A alleles an individual had, the larger their amygdala volume. Furthermore, two three-single nucleotide polymorphism haplotypes, including the rs2254298 G allele, showed significant associations with a smaller bilateral amygdala volume (Inoue et al., <xref ref-type="bibr" rid="B61">2010</xref>). These associations between <italic>OXTR</italic> polymorphism and amygdala volume could provide a hypothesis that explains how OXTR gene variants may increase the risk of psychopathologies (Furman et al., <xref ref-type="bibr" rid="B47">2011</xref>). In addition, as stated above, the A/A genotype in rs53576 is associated with significantly smaller bilateral amygdala volumes and reduced resting-state bilateral coupling between amygdala and the prefrontal cortex, specifically in women (Wang et al., <xref ref-type="bibr" rid="B128">2014</xref>).</p>
</sec>
<sec>
<title>Amygdala activation</title>
<p>Sauer et al. (<xref ref-type="bibr" rid="B111">2013</xref>), studying the interaction between OXT plasma levels and the dopamine system, specifically the common catechol-O-methyltransferase (COMT) val158met polymorphism (a polymorphism known to influence COMT activity and, consequently, dopamine degradation at synapses), analyzed amygdala activation after the presentation of social stimuli following placebo or OXT infusions. Their results showed no gene main effect and no gene × substance interaction, but a significant gene × gene × substance interaction. Indeed, using various social stimuli paradigms, the authors found that, when given placebo, the effect of CD38 on bilateral amygdala activation was modulated by the COMT genotype; by contrast, no such COMT genotype dependence was observed following the administration of OXT (Sauer et al., <xref ref-type="bibr" rid="B111">2013</xref>). These result are consistent with the report of Baumgartner et al. (<xref ref-type="bibr" rid="B10">2008</xref>), who found that intranasal infusions of OXT, in addition to making subjects insensitive to unreciprocated trust (as measured with a Trust game) show reduced activation of the amygdala and the dorsal striatum when faced with social stimuli (specifically social betrayal), as compared to a placebo group (see also Hurlemann et al., <xref ref-type="bibr" rid="B60">2010</xref>).</p>
<p>Regarding <italic>AVPR</italic>, Meyer-Lindenberg et al. (<xref ref-type="bibr" rid="B95">2009</xref>) showed that two risky alleles in <italic>AVPR1A</italic>, the RS1 334 bp and the RS3 320 bp alleles (which have been reported to have significant transmission to autistic probands) are associated with opposing effects on amygdala activation in an emotional face-matching task, a simple perceptual task previously described to robustly engage the amygdala. In this task, subjects must decide which one of two faces is (emotionally) identical to a target face (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B95">2009</xref>). The authors found that the 334 bp RS1 allele was associated with stronger bilateral responses of the amygdala, whereas the 320 bp RS3 carriers showed a smaller activation of the left amygdala. However, there was no association between these alleles and behavioral performance (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B95">2009</xref>).</p>
</sec>
<sec>
<title>Promoter activity</title>
<p>Both RS1 and RS3 showed differences in relative promoter activity, as measured in the human neuroblastoma cell line SH-SY5Y, with shorter repeat alleles of RS1 and RS3 showing decreased relative promoter activity (Tansey et al., <xref ref-type="bibr" rid="B117">2011</xref>).</p>
</sec>
<sec>
<title>Epigenetic effects</title>
<p>Recent findings by Reiner et al. (<xref ref-type="bibr" rid="B107">2015</xref>), in a sample of 43 clinically depressed and 42 healthy female subjects, suggest epigenetic effects of the <italic>OXTR</italic> rs53576 genotype on the patterns of methylation in exon 1 and 2 of <italic>OXTR</italic>. This <italic>OXTR</italic> SNP moderated, for instance, the association between depression and <italic>OXTR</italic> exon 1 methylation level. In this exon, a decreased methylation state was associated with depression. This kind of findings becomes more important now that strong evidence suggests that specific genotypes show altered levels of DNA methylation throughout the whole genome, depending on early environment (Dadds et al., <xref ref-type="bibr" rid="B30">2013</xref>; Chen et al., <xref ref-type="bibr" rid="B26">2015</xref>).</p>
</sec>
</sec>
</sec>
<sec>
<title>Effects of intranasal administration of OXT and AVP on psychiatric symptoms</title>
<p>The evidence on the effects of intranasal applications of OXT and AVP on clinical populations expressing a mental disorder is relatively sparse, and echoes the mixed findings for healthy population. However, the use of intranasal OXT for the treatment of psychiatric disorders shows some promise, particularly for treating symptoms involving deficits in social functioning, such as autism, schizophrenia, borderline personality, and social anxiety disorders (Macdonald and Macdonald, <xref ref-type="bibr" rid="B88">2010</xref>; MacDonald et al., <xref ref-type="bibr" rid="B86">2011</xref>; Anagnostou et al., <xref ref-type="bibr" rid="B3">2012</xref>; Macdonald and Feifel, <xref ref-type="bibr" rid="B87">2012</xref>; Bakermans-Kranenburg and Van Ijzendoorn, <xref ref-type="bibr" rid="B7">2013</xref>; Bethlehem et al., <xref ref-type="bibr" rid="B14">2013</xref>; De Berardis et al., <xref ref-type="bibr" rid="B31">2013</xref>; Tachibana et al., <xref ref-type="bibr" rid="B116">2013</xref>; Veening and Olivier, <xref ref-type="bibr" rid="B126">2013</xref>; Cardoso et al., <xref ref-type="bibr" rid="B21">2014</xref>). For instance, intranasal OXT has been shown to increase eye contact in individuals with ASD, possibly by increasing the saliency of social stimuli (Auyeung et al., <xref ref-type="bibr" rid="B6">2015</xref>). Similarly, intranasal OXT, in ASD patients, improves the ability to recognize the social emotions of others, as measured both at the behavioral and neural levels (Aoki et al., <xref ref-type="bibr" rid="B4">2014</xref>). In addition, OXT may selectively affect the salience and hedonic assessments of socially meaningful stimuli in subjects with ASD, and thus help social attunement (Domes et al., <xref ref-type="bibr" rid="B36">2013</xref>; Gordon et al., <xref ref-type="bibr" rid="B49">2013</xref>).</p>
<p>In individuals with Borderline Personality Disorder (BPD), OXT administration has shown that the effects may differ depending on baseline conditions, such as the participant's representations and expectations and/or an OXT system that is not working properly. For instance, Bartz et al. (<xref ref-type="bibr" rid="B9">2011</xref>) tested whether OXT administration improves trust and cooperative behaviors in individuals with BPD vs. healthy controls, using the Assurance Game (a variation of the Prisoner's dilemma; Kreps et al., <xref ref-type="bibr" rid="B72">1982</xref>; Brosnan et al., <xref ref-type="bibr" rid="B17">2011</xref>). They found that participants with BPD expected their partners to be less cooperative after administration of OXT, showing the opposite effect compared to healthy controls, where OXT infusions increase trust (Kosfeld et al., <xref ref-type="bibr" rid="B71">2005</xref>; Bartz et al., <xref ref-type="bibr" rid="B9">2011</xref>). In addition, intranasal administration of OXT in schizophrenic populations has shown an anxiolytic (Bell et al., <xref ref-type="bibr" rid="B12">2006</xref>), antidepressant (Ozsoy et al., <xref ref-type="bibr" rid="B100">2009</xref>), and antipsychotic effect (Caldwell et al., <xref ref-type="bibr" rid="B19">2009</xref>; Kuehn, <xref ref-type="bibr" rid="B74">2011</xref>; Macdonald and Feifel, <xref ref-type="bibr" rid="B87">2012</xref>; De Berardis et al., <xref ref-type="bibr" rid="B31">2013</xref>).</p>
<p>Surprisingly, there is very limited evidence linking OXT administration to social anxiety disorder (SAD). Guastella et al. (<xref ref-type="bibr" rid="B52">2009</xref>) examined the effect of OXT administration as an adjunct to therapy for SAD, finding that patients treated with OXT showed significant differences in their ratings of speech performance and speech appearance compared to patients treated with placebo. Similarly, Labuschagne et al. (<xref ref-type="bibr" rid="B75">2010</xref>) showed, using an emotional face matching paradigm as measure, that intranasal OXT reduced amygdala reactivity to fearful faces in participants diagnosed with SAD (Labuschagne et al., <xref ref-type="bibr" rid="B75">2010</xref>). In addition, the same group showed that intranasal OXT administered to SAD participants reduced cortical hyperactivity in the medial prefrontal cortex to sad faces to a level comparable to that of controls. Taken together, these studies indicate that OXT administration modulates the fear-related neural circuitry, consistent with previous research showing pro-social effects of OXT administration in healthy individuals.</p>
<p>Nevertheless, and as a cautionary note, a recent meta-analysis examining the effect of intranasal OXT across various clinical samples (i.e., ASD, social anxiety, depression, obsessive-compulsive disorder, schizophrenia, borderline personality disorder, and post-traumatic stress disorder) found only a small to moderate effect on psychiatric symptomatology and social competence indicators (Bakermans-Kranenburg and Van Ijzendoorn, <xref ref-type="bibr" rid="B7">2013</xref>). Moreover, Macdonald and Macdonald (<xref ref-type="bibr" rid="B88">2010</xref>) suggested that the context-dependent and divergent effects of OXT indicate that the effects of such OXT treatments may depend on individual differences (i.e., modulation by sex, hormonal and psychiatric status, and attachment style). The available evidence reveals that chronic administration of OXT causes mixed results, even within groups afflicted by the same disorder (Tachibana et al., <xref ref-type="bibr" rid="B116">2013</xref>; Dadds et al., <xref ref-type="bibr" rid="B29">2014</xref>). In addition, the effects of acute vs. chronic OXT administration have not been thoroughly studied; thus, their relative merit for the treatment of psychiatric disorders is unknown. Although promising, the specific effects of OXT on psychiatric symptomatology remain unclear.</p>
<p>Surprisingly, there is little research on the impact of intransal AVP administration on psychiatric symptoms. Some studies have suggested a link between AVP levels and psychiatric disorders. For instance, cerebrospinal fluid AVP levels have been positively correlated with a life history of interpersonal aggression in individuals with personality disorders (Coccaro et al., <xref ref-type="bibr" rid="B27">1998</xref>). Similarly, Pitman et al. (<xref ref-type="bibr" rid="B101">1993</xref>) investigated the effects of OXT and AVP on the emotional response of Vietnam veterans with PTSD during personal combat imagery exercises. Responses, measured by determining skin conductance, heart rate, and electromyographic responses, showed that the group that received AVP presented higher reactivity to combat imagery relative to the OXT and placebo groups, suggesting that AVP may enhance the emotional valence of events (Coccaro et al., <xref ref-type="bibr" rid="B27">1998</xref>).</p>
<p>In healthy populations, intranasal AVP has been shown to also improve social recognition. For example, Guastella et al. (<xref ref-type="bibr" rid="B51">2010a</xref>) conducted a study where healthy males were asked to view faces displaying happy, neutral, or angry expressions. Using a “surprise memory test,” they showed that participants who received AVP were more likely to remember happy and angry faces compared to participants who received placebo (Guastella et al., <xref ref-type="bibr" rid="B53">2010b</xref>). These results suggest that AVP also enhances human recognition of emotionally-valenced faces.</p>
<p>The very limited research using intranasal administration of AVP (Coccaro et al., <xref ref-type="bibr" rid="B27">1998</xref>; Guastella et al., <xref ref-type="bibr" rid="B53">2010b</xref>) has, nevertheless, revealed that this neuropeptide can exert important effects on social information processing. The results discussed above largely suggest that AVP may play a role in the processing of emotionally-valenced information in both healthy and clinical population.</p>
</sec>
</sec>
<sec id="s5" sec-type="discussion">
<title>Discussion</title>
<p>A growing body of research has found associations between alleles of <italic>OXTR</italic> and <italic>AVPR</italic> and human social and pathological behavior, such as altruism (Knafo et al., <xref ref-type="bibr" rid="B70">2008</xref>), generosity (Zak et al., <xref ref-type="bibr" rid="B136">2007</xref>) and aggression (Luppino et al., <xref ref-type="bibr" rid="B85">2014</xref>); depression (Van West et al., <xref ref-type="bibr" rid="B125">2004</xref>; Apter-Levy et al., <xref ref-type="bibr" rid="B5">2013</xref>; Thompson et al., <xref ref-type="bibr" rid="B124">2014</xref>), empathy (Wu et al., <xref ref-type="bibr" rid="B130">2012</xref>; Luo et al., <xref ref-type="bibr" rid="B83">2015a</xref>,<xref ref-type="bibr" rid="B84">b</xref>), autism (Wu et al., <xref ref-type="bibr" rid="B131">2005</xref>; Jacob et al., <xref ref-type="bibr" rid="B66">2007</xref>; Kelemenova et al., <xref ref-type="bibr" rid="B68">2010</xref>; Tansey et al., <xref ref-type="bibr" rid="B117">2011</xref>; Nyffeler et al., <xref ref-type="bibr" rid="B99">2014</xref>), stress (Thompson et al., <xref ref-type="bibr" rid="B123">2011</xref>; Thompson and Holman, <xref ref-type="bibr" rid="B122">2013</xref>), and schizophrenia (Golimbet et al., <xref ref-type="bibr" rid="B48">2015</xref>; Levin et al., <xref ref-type="bibr" rid="B78">2015</xref>). However, these results remain preliminary, and await further studies using other populations. As a cautionary note, a recent meta-analysis performed by Bakermans-Kranenburg and van Ijzendoorn (<xref ref-type="bibr" rid="B8">2014</xref>), found no significant association between any of five outcomes (i.e., biology, personality, social behavior, psychopathology, and autism) and the SNPs rs53576 and rs2254298 (reviewed above), concluding that these polymorphisms failed to explain a significant part of human social behavioral diversity (Bakermans-Kranenburg and van Ijzendoorn, <xref ref-type="bibr" rid="B8">2014</xref>).</p>
<sec>
<title>Functionality</title>
<p>A point to keep in mind is the old maxim “correlation does not imply causation.” This means that a robust result associating, for instance, a rs53576 polymorphism with a predisposition to depression, does not imply that there exists a causal relationship between the two variables. However, such an association does have some inherent value: if we cannot find evidence showing a causal relationship (or if this relationship does not exist at all!), the data may still provide useful information, such as pointing to a genetic region where the relevant gene is located (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). That correlation does not imply causation also raises questions about the impact of polymorphisms on gene function described in the literature. In other words, one may ask: Do the OXTR's SNPs and AVPR's SSRs play a role in causing the differences in phenotypic traits? Or, alternatively: Do these variants lack functionality or do they just result from “spurious” correlations? Yet, recent research is showing that these polymorphisms are indeed associated with different volumes of some neural structures (Inoue et al., <xref ref-type="bibr" rid="B61">2010</xref>; Furman et al., <xref ref-type="bibr" rid="B47">2011</xref>), differential neuronal connectivity or activation (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B95">2009</xref>; Sauer et al., <xref ref-type="bibr" rid="B111">2013</xref>); differential expression of the receptors (Young et al., <xref ref-type="bibr" rid="B134">1999</xref>; Knafo et al., <xref ref-type="bibr" rid="B70">2008</xref>), plasmatic levels of the peptides (Moons et al., <xref ref-type="bibr" rid="B96">2014</xref>), or promotor activity (Tansey et al., <xref ref-type="bibr" rid="B117">2011</xref>). This suggests that neuropeptide receptor polymorphisms likely do have a functional role in normal and pathological human behavior. Anyway, there are also practical benefits to identifying individuals at risk even without knowing the mechanisms responsible for the deficit (Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>): for instance, there are treatments and tests available that are offered on the basis of calculated risk (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>).</p>
</sec>
<sec>
<title>Thinking about normal and psychopathic behavior as a continuum</title>
<p>It is noteworthy that both the normal and pathological behaviors covered in this review are most certainly quantitative traits, involving interactions among more than one gene, and for which the phenotypes of interest are better described as a continuum. Consequently, the field needs to emphasize polygenic association studies where, instead of a single gene underlying a trait, there are multiple (functional) gene variants involved, each making small quantitative contributions to the final phenotype (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>; Brookfield, <xref ref-type="bibr" rid="B16">2010</xref>). This notion (namely, that many genes influence complex disorders or personality traits) raises the question of why such disorders are typically diagnosed as qualitative, and not as quantitative traits, with a continuum of genetic risk. This quantitative approach allows one to formulate two models: the liability threshold model, where risk is distributed normally and disorders occur in a qualitative fashion, when a threshold is exceeded (genetic continuum with discrete phenotypes), vs. a model that proposes that phenotypes change continuously from normal to abnormal, with diagnosed cases being extreme cases that differ quantitatively, but not qualitatively (Plomin et al., <xref ref-type="bibr" rid="B102">2008</xref>). The latter seems to be the best descriptor for depression and alcoholism, and even for schizophrenia. It also allows finding genes that may be associated with depression in afflicted patients and with mood changes in normal patients.</p>
</sec>
<sec>
<title>Finally: what do we still not know?</title>
<p>GWAS promises to be a powerful tool for constructing the complete landscape of interacting genes but, given its current cost, have not replaced research that investigates candidate genes in polygenic association studies. To date, in addition to <italic>OXTR</italic> and <italic>AVPR</italic> SNPs and SSRs, polymorphisms in <italic>COMT, CD38, HTTLPR, HTR2A</italic> and <italic>DAT</italic> are likely to be good candidates for studying the genetic bases of human social and pathological behavior. Curiously, the <italic>OXTR</italic> SNP rs53576 is not present on many currently available chips that are used for genome-wide association studies of ASD (Meyer-Lindenberg et al., <xref ref-type="bibr" rid="B94">2011</xref>), limiting their use for such studies.</p>
<p>In addition, an open challenge is to determine the exact mechanism by which neuropeptides influence psychiatric symptoms. Although some reports are shedding light on the impact of different gene polymorphisms on socially relevant behaviors and their associated psychiatric disorders, the complete pathways between genes, gene interactions and behavior is still a black dark forest. As told by Chomsky, “there's a famous joke about a drunk under a lamppost looking for a pencil dropped on the ground. Somebody comes up and asks ‘What are you looking for?’ He says, ‘I’m looking for a pencil that I dropped.' ‘Well, where did you drop it?’ He says, ‘Oh, I dropped it across the street.’ ‘Well, why are looking here?’ ‘This is where there is light.’ That's the way the sciences work. […] If you try to move it a little further, maybe ultimately you'll get across the street.”</p>
</sec>
</sec>
<sec>
<title>Author contributions</title>
<p>MA, MM, MR, AR, and JE had fun conceiving, drafting and critically revising this review.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>MA and MR thanks CONICYT: Project “Anillo en Complejidad Social” SOC-1101. MA and JE thank FONDECYT (#1141278) and Centro Interdisciplinario de Neurociencia de Valparaíso [P09-022-F], which is supported by the Millennium Scientific Initiative of the Ministerio de Economía, Fomento y Turismo. The authors also thank the graphical artist, Juan Carlos Aspé, for his creative drawing of figures for this paper.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aebi</surname><given-names>M.</given-names></name><name><surname>van Donkelaar</surname><given-names>M. M.</given-names></name><name><surname>Poelmans</surname><given-names>G.</given-names></name><name><surname>Buitelaar</surname><given-names>J. K.</given-names></name><name><surname>Sonuga-Barke</surname><given-names>E. J.</given-names></name><name><surname>Faraone</surname><given-names>S. V.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Gene-set and multivariate genome-wide association analysis of oppositional defiant behavior subtypes in attention-deficit/hyperactivity disorder</article-title>. <source/>Am. J. Med. Genet. B. Neuropsychiatr. Genet. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1002/ajmg.b.32346</pub-id><pub-id pub-id-type="pmid">26184070</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amir</surname><given-names>R. E.</given-names></name><name><surname>Van den Veyer</surname><given-names>I. B.</given-names></name><name><surname>Wan</surname><given-names>M.</given-names></name><name><surname>Tran</surname><given-names>C. Q.</given-names></name><name><surname>Francke</surname><given-names>U.</given-names></name><name><surname>Zoghbi</surname><given-names>H. Y.</given-names></name></person-group> (<year>1999</year>). <article-title>Rett syndrome is caused by mutations in X-linked M ECP2, encoding m ethyl-CpG -binding protein 2</article-title>. <source/>Nat. Genet.
<volume>23</volume>, <fpage>185</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/13810</pub-id><pub-id pub-id-type="pmid">10508514</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anagnostou</surname><given-names>E.</given-names></name><name><surname>Soorya</surname><given-names>L.</given-names></name><name><surname>Chaplin</surname><given-names>W.</given-names></name><name><surname>Bartz</surname><given-names>J.</given-names></name><name><surname>Halpern</surname><given-names>D.</given-names></name><name><surname>Wasserman</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial</article-title>. <source/>Mol. Autism.
<volume>3</volume>, <fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-3-16</pub-id><pub-id pub-id-type="pmid">23216716</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>Y.</given-names></name><name><surname>Yahata</surname><given-names>N.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name><name><surname>Takano</surname><given-names>Y.</given-names></name><name><surname>Kawakubo</surname><given-names>Y.</given-names></name><name><surname>Kuwabara</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism</article-title>. <source/>Brain
<volume>137</volume>, <fpage>3073</fpage>–<lpage>3086</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awu231</pub-id><pub-id pub-id-type="pmid">25149412</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apter-Levy</surname><given-names>Y.</given-names></name><name><surname>Feldman</surname><given-names>M.</given-names></name><name><surname>Vakart</surname><given-names>A.</given-names></name><name><surname>Ebstein</surname><given-names>R. P.</given-names></name><name><surname>Feldman</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Impact of maternal depression across the first 6 years of life on the child's mental health, social engagement, and empathy: the moderating role of oxytocin</article-title>. <source/>Am. J. Psychiatry
<volume>170</volume>, <fpage>1161</fpage>–<lpage>1168</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2013.12121597</pub-id><pub-id pub-id-type="pmid">23846912</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auyeung</surname><given-names>B.</given-names></name><name><surname>Lombardo</surname><given-names>M. V.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name><name><surname>Chakrabarti</surname><given-names>B.</given-names></name><name><surname>Sule</surname><given-names>A.</given-names></name><name><surname>Deakin</surname><given-names>J. B.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism</article-title>. <source/>Transl. Psychiatry
<volume>5</volume>:<fpage>e507</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2014.146</pub-id><pub-id pub-id-type="pmid">25668435</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakermans-Kranenburg</surname><given-names>M. J.</given-names></name><name><surname>Van Ijzendoorn</surname><given-names>M. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy</article-title>. <source/>Transl. Psychiatry
<volume>3</volume>:<fpage>e258</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2013.34</pub-id><pub-id pub-id-type="pmid">23695233</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakermans-Kranenburg</surname><given-names>M. J.</given-names></name><name><surname>van Ijzendoorn</surname><given-names>M. H.</given-names></name></person-group> (<year>2014</year>). <article-title>A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans</article-title>. <source/>Psychiatr. Genet.
<volume>24</volume>, <fpage>45</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e3283643684</pub-id><pub-id pub-id-type="pmid">23921259</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartz</surname><given-names>J.</given-names></name><name><surname>Simeon</surname><given-names>D.</given-names></name><name><surname>Hamilton</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Crystal</surname><given-names>S.</given-names></name><name><surname>Braun</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Oxytocin can hinder trust and cooperation in borderline personality disorder</article-title>. <source/>Soc. Cogn. Affect. Neurosci.
<volume>6</volume>, <fpage>556</fpage>–<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nsq085</pub-id><pub-id pub-id-type="pmid">21115541</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgartner</surname><given-names>T.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name><name><surname>Vonlanthen</surname><given-names>A.</given-names></name><name><surname>Fischbacher</surname><given-names>U.</given-names></name><name><surname>Fehr</surname><given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>Oxytocin shapes the neural circuitry of trust and trust adaptation in humans</article-title>. <source/>Neuron
<volume>58</volume>, <fpage>639</fpage>–<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2008.04.009</pub-id><pub-id pub-id-type="pmid">18498743</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beery</surname><given-names>A. K.</given-names></name><name><surname>Lacey</surname><given-names>E. A.</given-names></name><name><surname>Francis</surname><given-names>D. D.</given-names></name></person-group> (<year>2008</year>). <article-title>Oxytocin and vasopressin receptor distributions in a solitary and a social species of tuco-tuco (Ctenomys haigi and <italic>Ctenomys sociabilis</italic>)</article-title>. <source/>J. Comp. Neurol.
<volume>507</volume>, <fpage>1847</fpage>–<lpage>1859</lpage>. <pub-id pub-id-type="doi">10.1002/cne.21638</pub-id><pub-id pub-id-type="pmid">18271022</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>C. J.</given-names></name><name><surname>Nicholson</surname><given-names>H.</given-names></name><name><surname>Mulder</surname><given-names>R. T.</given-names></name><name><surname>Luty</surname><given-names>S. E.</given-names></name><name><surname>Joyce</surname><given-names>P. R.</given-names></name></person-group> (<year>2006</year>). <article-title>Plasma oxytocin levels in depression and their correlation with the temperament dimension of reward dependence</article-title>. <source/>J. Psychopharmacol.
<volume>20</volume>, <fpage>656</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1177/0269881106060512</pub-id><pub-id pub-id-type="pmid">16401658</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>D. J.</given-names></name><name><surname>Cesarini</surname><given-names>D.</given-names></name><name><surname>van der Loos</surname><given-names>M. J. H. M.</given-names></name><name><surname>Dawes</surname><given-names>C. T.</given-names></name><name><surname>Koellinger</surname><given-names>P. D.</given-names></name><name><surname>Magnusson</surname><given-names>P. K. E.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The genetic architecture of economic and political preferences</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>109</volume>, <fpage>8026</fpage>–<lpage>8031</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1120666109</pub-id><pub-id pub-id-type="pmid">22566634</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bethlehem</surname><given-names>R. A.</given-names></name><name><surname>Van Honk</surname><given-names>J.</given-names></name><name><surname>Auyeung</surname><given-names>B.</given-names></name><name><surname>Baron-Cohen</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies</article-title>. <source/>Psychoneuroendocrinology
<volume>38</volume>, <fpage>962</fpage>–<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2012.10.011</pub-id><pub-id pub-id-type="pmid">23159011</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccia</surname><given-names>M. L.</given-names></name><name><surname>Petrusz</surname><given-names>P.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Marson</surname><given-names>L.</given-names></name><name><surname>Pedersen</surname><given-names>C. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Immunohistochemical localization of oxytocin receptors in human brain</article-title>. <source/>Neuroscience
<volume>253</volume>, <fpage>155</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.08.048</pub-id><pub-id pub-id-type="pmid">24012742</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brookfield</surname><given-names>J. F.</given-names></name></person-group> (<year>2010</year>). <article-title>Q&amp;A: promise and pitfalls of genome-wide association studies</article-title>. <source/>BMC Biol.
<volume>8</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7007-8-41</pub-id><pub-id pub-id-type="pmid">20385035</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brosnan</surname><given-names>S. F.</given-names></name><name><surname>Parrish</surname><given-names>A.</given-names></name><name><surname>Beran</surname><given-names>M. J.</given-names></name><name><surname>Flemming</surname><given-names>T.</given-names></name><name><surname>Heimbauer</surname><given-names>L.</given-names></name><name><surname>Talbot</surname><given-names>C. F.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Responses to the Assurance game in monkeys, apes, and humans using equivalent procedures</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>108</volume>, <fpage>3442</fpage>–<lpage>3447</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1016269108</pub-id><pub-id pub-id-type="pmid">21300874</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caldwell</surname><given-names>H. K.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Macbeth</surname><given-names>A. H.</given-names></name><name><surname>Young</surname><given-names>W. S.</given-names></name></person-group> (<year>2008</year>). <article-title>Vasopressin: behavioral roles of an “original” neuropeptide</article-title>. <source/>Prog. Neurobiol.
<volume>84</volume>, <fpage>1</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2007.10.007</pub-id><pub-id pub-id-type="pmid">18053631</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caldwell</surname><given-names>H. K.</given-names></name><name><surname>Stephens</surname><given-names>S. L.</given-names></name><name><surname>Young</surname><given-names>W. S.</given-names></name></person-group> (<year>2009</year>). <article-title>Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice</article-title>. <source/>Mol. Psychiatry
<volume>14</volume>, <fpage>190</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4002150</pub-id><pub-id pub-id-type="pmid">18227836</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardon</surname><given-names>L. R.</given-names></name><name><surname>Abecasis</surname><given-names>G. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Using haplotype blocks to map human complex trait loci</article-title>. <source/>Trends Genet.
<volume>19</volume>, <fpage>135</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-9525(03)00022-2</pub-id><pub-id pub-id-type="pmid">12615007</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>C.</given-names></name><name><surname>Kingdon</surname><given-names>D.</given-names></name><name><surname>Ellenbogen</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>A meta-analytic review of the impact of intranasal oxytocin administration on cortisol concentrations during laboratory tasks: moderation by method and mental health</article-title>. <source/>Psychoneuroendocrinology
<volume>49</volume>, <fpage>161</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.07.014</pub-id><pub-id pub-id-type="pmid">25086828</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesarini</surname><given-names>D.</given-names></name><name><surname>Dawes</surname><given-names>C. T.</given-names></name><name><surname>Fowler</surname><given-names>J. H.</given-names></name><name><surname>Johannesson</surname><given-names>M.</given-names></name><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Wallace</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Heritability of cooperative behavior in the trust game</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>105</volume>, <fpage>3721</fpage>–<lpage>3726</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0710069105</pub-id><pub-id pub-id-type="pmid">18316737</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cesarini</surname><given-names>D.</given-names></name><name><surname>Dawes</surname><given-names>C. T.</given-names></name><name><surname>Johannesson</surname><given-names>M.</given-names></name><name><surname>Lichtenstein</surname><given-names>P.</given-names></name><name><surname>Wallace</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic variation in preferences for giving and risk taking</article-title>. <source/>Q. J. Econ.
<volume>12</volume>, <fpage>809</fpage>–<lpage>842</lpage>. <pub-id pub-id-type="doi">10.1162/qjec.2009.124.2.809</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>W. H.</given-names></name><name><surname>Lee</surname><given-names>I. H.</given-names></name><name><surname>Chen</surname><given-names>K. C.</given-names></name><name><surname>Chi</surname><given-names>M. H.</given-names></name><name><surname>Chiu</surname><given-names>N. T.</given-names></name><name><surname>Yao</surname><given-names>W. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Oxytocin receptor gene rs53576 polymorphism modulates oxytocin-dopamine interaction and neuroticismtraits –a SPECT study</article-title>. <source/>Psychoneuroendocrinology
<volume>47</volume>, <fpage>212</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.05.020</pub-id><pub-id pub-id-type="pmid">25001970</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F. S.</given-names></name><name><surname>Kumsta</surname><given-names>R.</given-names></name><name><surname>von Dawans</surname><given-names>B.</given-names></name><name><surname>Monakhov</surname><given-names>M.</given-names></name><name><surname>Ebstein</surname><given-names>R. P.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>108</volume>, <fpage>19937</fpage>–<lpage>19942</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1113079108</pub-id><pub-id pub-id-type="pmid">22123970</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Pan</surname><given-names>H.</given-names></name><name><surname>Tuan</surname><given-names>T. A.</given-names></name><name><surname>Teh</surname><given-names>A. L.</given-names></name><name><surname>MacIsaac</surname><given-names>J. L.</given-names></name><name><surname>Mah</surname><given-names>S. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism influences the association of the methylome with maternal anxiety and neonatal brain volumes</article-title>. <source/>Dev. Psychopathol.
<volume>27</volume>, <fpage>137</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1017/S0954579414001357</pub-id><pub-id pub-id-type="pmid">25640836</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coccaro</surname><given-names>E. F.</given-names></name><name><surname>Kavoussi</surname><given-names>R. J.</given-names></name><name><surname>Hauger</surname><given-names>R. L.</given-names></name><name><surname>Cooper</surname><given-names>T. B.</given-names></name><name><surname>Ferris</surname><given-names>C. F.</given-names></name></person-group> (<year>1998</year>). <article-title>Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects</article-title>. <source/>Arch. Gen. Psychiatry
<volume>55</volume>, <fpage>708</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.55.8.708</pub-id><pub-id pub-id-type="pmid">9707381</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottet</surname><given-names>M.</given-names></name><name><surname>Albizu</surname><given-names>L.</given-names></name><name><surname>Perkovska</surname><given-names>S.</given-names></name><name><surname>Jean-Alphonse</surname><given-names>F.</given-names></name><name><surname>Rahmeh</surname><given-names>R.</given-names></name><name><surname>Orcel</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes</article-title>. <source/>Curr. Opin. Pharmacol.
<volume>10</volume>, <fpage>59</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2009.10.003</pub-id><pub-id pub-id-type="pmid">19896898</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dadds</surname><given-names>M. R.</given-names></name><name><surname>MacDonald</surname><given-names>E.</given-names></name><name><surname>Cauchi</surname><given-names>A.</given-names></name><name><surname>Williams</surname><given-names>K.</given-names></name><name><surname>Levy</surname><given-names>F.</given-names></name><name><surname>Brennan</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial</article-title>. <source/>J. Autism Dev. Disord.
<volume>44</volume>, <fpage>521</fpage>–<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-013-1899-3</pub-id><pub-id pub-id-type="pmid">23888359</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dadds</surname><given-names>M. R.</given-names></name><name><surname>Moul</surname><given-names>C.</given-names></name><name><surname>Cauchi</surname><given-names>A.</given-names></name><name><surname>Dobson-Stone</surname><given-names>C.</given-names></name><name><surname>Hawes</surname><given-names>D. J.</given-names></name><name><surname>Brennan</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Methylation of the oxytocin receptor gene and oxytocin blood levels in the development of psychopathy</article-title>. <source/>Dev. Psychopathol. <volume>26</volume>, <fpage>33</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1017/S0954579413000497</pub-id><pub-id pub-id-type="pmid">24059811</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Berardis</surname><given-names>D.</given-names></name><name><surname>Marini</surname><given-names>S.</given-names></name><name><surname>Iasevoli</surname><given-names>F.</given-names></name><name><surname>Tomasetti</surname><given-names>C.</given-names></name><name><surname>De Bartolomeis</surname><given-names>A.</given-names></name><name><surname>Mazza</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review</article-title>. <source/>CNS Neurol. Disord. Drug Targets
<volume>12</volume>, <fpage>252</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.2174/1871527311312020012</pub-id><pub-id pub-id-type="pmid">23469841</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dempster</surname><given-names>E.</given-names></name><name><surname>Burcescu</surname><given-names>I.</given-names></name><name><surname>Wigg</surname><given-names>K.</given-names></name><name><surname>Kiss</surname><given-names>E.</given-names></name><name><surname>Baji</surname><given-names>I.</given-names></name><name><surname>Gadoros</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders</article-title>. <source/>Arch. Gen. Psychiatry
<volume>64</volume>, <fpage>1189</fpage>–<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.64.10.1189</pub-id><pub-id pub-id-type="pmid">17909131</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vignemont</surname><given-names>F.</given-names></name><name><surname>Singer</surname><given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>The empathic brain: how, when and why?</article-title>
<source/>Trends Cogn. Sci.
<volume>10</volume>, <fpage>435</fpage>–<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2006.08.008</pub-id><pub-id pub-id-type="pmid">16949331</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devost</surname><given-names>D.</given-names></name><name><surname>Zingg</surname><given-names>H. H.</given-names></name></person-group> (<year>2003</year>). <article-title>Identification of dimeric and oligomeric complexes of the human oxytocin receptor by co-immunoprecipitation and bioluminescence resonance energy transfer</article-title>. <source/>J. Mol. Endocrinol.
<volume>31</volume>, <fpage>461</fpage>–<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1677/jme.0.0310461</pub-id><pub-id pub-id-type="pmid">14664707</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Waal</surname><given-names>F. B. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Putting the altruism back into altruism: the evolution of empathy</article-title>. <source/>Annu. Rev. Psychol.
<volume>59</volume>, <fpage>279</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.psych.59.103006.093625</pub-id><pub-id pub-id-type="pmid">17550343</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domes</surname><given-names>G.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name><name><surname>Kumbier</surname><given-names>E.</given-names></name><name><surname>Grossmann</surname><given-names>A.</given-names></name><name><surname>Hauenstein</surname><given-names>K.</given-names></name><name><surname>Herpertz</surname><given-names>S. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder</article-title>. <source/>Biol. Psychiatry
<volume>74</volume>, <fpage>164</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2013.02.007</pub-id><pub-id pub-id-type="pmid">23510581</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dufwenberg</surname><given-names>M.</given-names></name><name><surname>Kirchsteiger</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>A theory of sequential reciprocity</article-title>. <source/>Games Econ. Behav.
<volume>47</volume>, <fpage>268</fpage>–<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.geb.2003.06.003</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebstein</surname><given-names>R. P.</given-names></name><name><surname>Israel</surname><given-names>S.</given-names></name><name><surname>Chew</surname><given-names>S. H.</given-names></name><name><surname>Zhong</surname><given-names>S.</given-names></name><name><surname>Knafo</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetics of human social behavior</article-title>. <source/>Neuron
<volume>65</volume>, <fpage>831</fpage>–<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.020</pub-id><pub-id pub-id-type="pmid">20346758</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebstein</surname><given-names>R. P.</given-names></name><name><surname>Israel</surname><given-names>S.</given-names></name><name><surname>Lerer</surname><given-names>E.</given-names></name><name><surname>Uzefovsky</surname><given-names>F.</given-names></name><name><surname>Shalev</surname><given-names>I.</given-names></name><name><surname>Gritsenko</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Arginine vasopressin and oxytocin modulate human social behavior</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>1167</volume>, <fpage>87</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.04541.x</pub-id><pub-id pub-id-type="pmid">19580556</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebstein</surname><given-names>R. P.</given-names></name><name><surname>Knafo</surname><given-names>A.</given-names></name><name><surname>Mankuta</surname><given-names>D.</given-names></name><name><surname>Chew</surname><given-names>S. H.</given-names></name><name><surname>Lai</surname><given-names>P. S.</given-names></name></person-group> (<year>2012</year>). <article-title>The contributions of oxytocin and vasopressin pathway genes to human behavior</article-title>. <source/>Horm. Behav.
<volume>61</volume>, <fpage>359</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2011.12.014</pub-id><pub-id pub-id-type="pmid">22245314</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>E.</given-names></name><name><surname>Camerer</surname><given-names>C. F.</given-names></name></person-group> (<year>2007</year>). <article-title>Social neuroeconomics: the neural circuitry of social preferences</article-title>. <source/>Trends Cogn. Sci.
<volume>11</volume>, <fpage>419</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1016/j.tics.2007.09.002</pub-id><pub-id pub-id-type="pmid">17913566</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>E.</given-names></name><name><surname>Schmidt</surname><given-names>K.</given-names></name></person-group> (<year>1999</year>). <article-title>A theory of fairness, competition, and cooperation</article-title>. <source/>Q. J. Econ.
<volume>114</volume>, <fpage>817</fpage>–<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1162/003355399556151</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feifel</surname><given-names>D.</given-names></name><name><surname>Reza</surname><given-names>T.</given-names></name></person-group> (<year>1999</year>). <article-title>Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating</article-title>. <source/>Psychopharmacology
<volume>141</volume>, <fpage>93</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s002130050811</pub-id><pub-id pub-id-type="pmid">9952070</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feifel</surname><given-names>D.</given-names></name><name><surname>Shilling</surname><given-names>P. D.</given-names></name><name><surname>Belcher</surname><given-names>A. M.</given-names></name></person-group> (<year>2012</year>). <article-title>The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating</article-title>. <source/>Eur. Neuropsychopharmacol.
<volume>22</volume>, <fpage>374</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2011.09.004</pub-id><pub-id pub-id-type="pmid">21962914</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>S.</given-names></name><name><surname>Excoffier</surname><given-names>L.</given-names></name><name><surname>Heckel</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Mammalian monogamy is not controlled by a single gene</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>103</volume>, <fpage>10956</fpage>–<lpage>10960</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0602380103</pub-id><pub-id pub-id-type="pmid">16832060</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitag</surname><given-names>C. M.</given-names></name></person-group> (<year>2007</year>). <article-title>The genetics of autistic disorders and its clinical relevance: a review of the literatura</article-title>. <source/>Mol. Psychiatry
<volume>12</volume>, <fpage>2</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001896</pub-id><pub-id pub-id-type="pmid">17033636</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>D. J.</given-names></name><name><surname>Chen</surname><given-names>M. C.</given-names></name><name><surname>Gotlib</surname><given-names>I. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Variant in oxytocin receptor gene is associated with amygdala volume</article-title>. <source/>Psychoneuroendocrinology
<volume>36</volume>, <fpage>891</fpage>–<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2010.12.004</pub-id><pub-id pub-id-type="pmid">21208749</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golimbet</surname><given-names>V.</given-names></name><name><surname>Alfimova</surname><given-names>M.</given-names></name><name><surname>Abramova</surname><given-names>L.</given-names></name><name><surname>Kaleda</surname><given-names>V.</given-names></name><name><surname>Gritsenko</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>Arginine vasopressin 1a receptor RS3 promoter microsatellites in schizophrenia: a study of the effect of the “risk” allele on clinical symptoms and facial affect recognition</article-title>. <source/>Psychiatry Res.
<volume>225</volume>, <fpage>739</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2014.11.043</pub-id><pub-id pub-id-type="pmid">25529259</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>I.</given-names></name><name><surname>Vander Wyk</surname><given-names>B. C.</given-names></name><name><surname>Bennett</surname><given-names>R. H.</given-names></name><name><surname>Cordeaux</surname><given-names>C.</given-names></name><name><surname>Lucas</surname><given-names>M. V.</given-names></name><name><surname>Eilbott</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Oxytocin enhances brain function in children with autism</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>110</volume>, <fpage>20953</fpage>–<lpage>20958</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1312857110</pub-id><pub-id pub-id-type="pmid">24297883</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gottesman</surname><given-names>I.</given-names></name></person-group> (<year>1991</year>). <source/>Schizophrenia Genesis: The Origins of Madness. A Series of Books in Psychology. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>W H Freeman, Times Books, Henry Holt and Co</publisher-name>.</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>A. J.</given-names></name><name><surname>Einfeld</surname><given-names>S. L.</given-names></name><name><surname>Gray</surname><given-names>K. M.</given-names></name><name><surname>Rinehart</surname><given-names>N. J.</given-names></name><name><surname>Tonge</surname><given-names>B. J.</given-names></name><name><surname>Lambert</surname><given-names>T. J.</given-names></name><etal></etal></person-group>. (<year>2010a</year>). <article-title>Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders</article-title>. <source/>Biol. Psychiatry
<volume>67</volume>, <fpage>692</fpage>–<lpage>694</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2009.09.020</pub-id><pub-id pub-id-type="pmid">19897177</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>A. J.</given-names></name><name><surname>Howard</surname><given-names>A. L.</given-names></name><name><surname>Dadds</surname><given-names>M. R.</given-names></name><name><surname>Mitchell</surname><given-names>P.</given-names></name><name><surname>Carson</surname><given-names>D. S.</given-names></name></person-group> (<year>2009</year>). <article-title>A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder</article-title>. <source/>Psychoneuroendocrinology
<volume>34</volume>, <fpage>917</fpage>–<lpage>923</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2009.01.005</pub-id><pub-id pub-id-type="pmid">19246160</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guastella</surname><given-names>A. J.</given-names></name><name><surname>Kenyon</surname><given-names>A. R.</given-names></name><name><surname>Alvares</surname><given-names>G. A.</given-names></name><name><surname>Carson</surname><given-names>D. S.</given-names></name><name><surname>Hickie</surname><given-names>I. B.</given-names></name></person-group> (<year>2010b</year>). <article-title>Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans</article-title>. <source/>Biol. Psychiatry
<volume>67</volume>, <fpage>1220</fpage>–<lpage>1222</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.03.014</pub-id><pub-id pub-id-type="pmid">20447617</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammock</surname><given-names>E. A. D.</given-names></name><name><surname>Lim</surname><given-names>M. M.</given-names></name><name><surname>Nair</surname><given-names>H. P.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Association of vasopressin 1a receptor levels with a regulatory microsatellite and behavior</article-title>. <source/>Genes Brain Behav.
<volume>4</volume>, <fpage>289</fpage>–<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00119.x</pub-id><pub-id pub-id-type="pmid">16011575</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammock</surname><given-names>E. A. D.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Functional microsatellite polymorphism associated with divergent social structure in vole species</article-title>. <source/>Mol. Biol. Evol.
<volume>21</volume>, <fpage>1057</fpage>–<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msh104</pub-id><pub-id pub-id-type="pmid">15014156</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammock</surname><given-names>E. A. D.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Microsatellite instability generates diversity in brain and sociobehavioral traits</article-title>. <source/>Science
<volume>308</volume>, <fpage>1630</fpage>–<lpage>1634</lpage>. <pub-id pub-id-type="doi">10.1126/science.1111427</pub-id><pub-id pub-id-type="pmid">15947188</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haram</surname><given-names>M.</given-names></name><name><surname>Tesli</surname><given-names>M.</given-names></name><name><surname>Bettella</surname><given-names>F.</given-names></name><name><surname>Djurovic</surname><given-names>S.</given-names></name><name><surname>Andreassen</surname><given-names>O. A.</given-names></name><name><surname>Melle</surname><given-names>I.</given-names></name></person-group> (<year>2015</year>). <article-title>Association between genetic variation in the oxytocin receptor gene and emotional withdrawal, but not between oxytocin pathway genes and diagnosis in psychotic disorders</article-title>. <source/>Front. Hum. Neurosci.
<volume>9</volume>:<issue>9</issue>
<pub-id pub-id-type="doi">10.3389/fnhum.2015.00009</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>P. J.</given-names></name><name><surname>Law</surname><given-names>A. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology</article-title>. <source/>Biol. Psychiatry
<volume>60</volume>, <fpage>132</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.11.002</pub-id><pub-id pub-id-type="pmid">16442083</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Laird</surname><given-names>N. M.</given-names></name></person-group> (<year>2001</year>). <article-title>The family based association test method: strategies for studying general genotype–phenotype associations</article-title>. <source/>Eur. J. Hum. Genet.
<volume>9</volume>, <fpage>301</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ejhg.5200625</pub-id><pub-id pub-id-type="pmid">11313775</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurlemann</surname><given-names>R.</given-names></name><name><surname>Patin</surname><given-names>A.</given-names></name><name><surname>Onur</surname><given-names>O. A.</given-names></name><name><surname>Cohen</surname><given-names>M. X.</given-names></name><name><surname>Baumgartner</surname><given-names>T.</given-names></name><name><surname>Metzler</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans</article-title>. <source/>J. Neurosci. <volume>30</volume>, <fpage>4999</fpage>–<lpage>5007</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5538-09.2010</pub-id><pub-id pub-id-type="pmid">20371820</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Yamasue</surname><given-names>H.</given-names></name><name><surname>Tochigi</surname><given-names>M.</given-names></name><name><surname>Takei</surname><given-names>K.</given-names></name><name><surname>Suga</surname><given-names>M.</given-names></name><name><surname>Abe</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Effect of tryptophan hydroxylase-2 gene variants on amygdalar and hippocampal volumes</article-title>. <source/>Brain Res. <volume>1331</volume>, <fpage>51</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.03.057</pub-id><pub-id pub-id-type="pmid">20331984</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Kimura</surname><given-names>T.</given-names></name><name><surname>Azuma</surname><given-names>C.</given-names></name><name><surname>Inazawa</surname><given-names>J.</given-names></name><name><surname>Takemura</surname><given-names>M.</given-names></name><name><surname>Kikuchi</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Structural organization of the human oxytocin receptor gene</article-title>. <source/>J. Biol. Chem.
<volume>269</volume>, <fpage>32451</fpage>–<lpage>32456</lpage>. <pub-id pub-id-type="pmid">7798245</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T. R.</given-names></name></person-group> (<year>2010</year>). <article-title>The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior</article-title>. <source/>Neuron
<volume>65</volume>, <fpage>768</fpage>–<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.03.005</pub-id><pub-id pub-id-type="pmid">20346754</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T. R.</given-names></name><name><surname>Shapiro</surname><given-names>L. E.</given-names></name></person-group> (<year>1992</year>). <article-title>Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles</article-title>. <source/>Proc. Nat. Acad. Sci. U.S.A.
<volume>89</volume>, <fpage>5981</fpage>–<lpage>5985</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1992.tb34380.x</pub-id><pub-id pub-id-type="pmid">1321430</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Israel</surname><given-names>S.</given-names></name><name><surname>Lerer</surname><given-names>E.</given-names></name><name><surname>Shalev</surname><given-names>I.</given-names></name><name><surname>Uzefovsky</surname><given-names>F.</given-names></name><name><surname>Riebold</surname><given-names>M.</given-names></name><name><surname>Laiba</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>The oxytocin receptor (OXTR) contributes to prosocial fund allocations in the dictator game and the social value orientations task</article-title>. <source/>PLoS ONE
<volume>4</volume>:<fpage>e5535</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0005535</pub-id><pub-id pub-id-type="pmid">19461999</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>S.</given-names></name><name><surname>Brune</surname><given-names>C. W.</given-names></name><name><surname>Carter</surname><given-names>C. S.</given-names></name><name><surname>Leventhal</surname><given-names>B. L.</given-names></name><name><surname>Lord</surname><given-names>C.</given-names></name><name><surname>Cook</surname><given-names>E. H. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism</article-title>. <source/>Neurosci. Lett.
<volume>417</volume>, <fpage>6</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2007.02.001</pub-id><pub-id pub-id-type="pmid">17383819</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Joiner</surname><given-names>T.</given-names></name><name><surname>Coyne</surname><given-names>J. C.</given-names></name></person-group> (eds.). (<year>1999</year>). <source/>The Interactional Nature of Depression: Advances in Interpersonal Approaches. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychological Association</publisher-name>.</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelemenova</surname><given-names>S.</given-names></name><name><surname>Schmidtova</surname><given-names>E.</given-names></name><name><surname>Ficek</surname><given-names>A.</given-names></name><name><surname>Celec</surname><given-names>P.</given-names></name><name><surname>Kubranska</surname><given-names>A.</given-names></name><name><surname>Ostatnikova</surname><given-names>D.</given-names></name></person-group> (<year>2010</year>). <article-title>Polymorphisms of candidate genes in Slovak autistic patients</article-title>. <source/>Psychiatr. Genet.
<volume>20</volume>, <fpage>137</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32833a1eb3</pub-id><pub-id pub-id-type="pmid">20436377</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. J.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name><name><surname>Gonen</surname><given-names>D.</given-names></name><name><surname>Veenstra-VanderWeele</surname><given-names>J.</given-names></name><name><surname>Courchesne</surname><given-names>R.</given-names></name><name><surname>Courchesne</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Transmission disequilibrium testing of arginine vasopressin receptor 1A (<italic>AVPR1A</italic>) polymorphisms in autism</article-title>. <source/>Mol. Psychiatry
<volume>7</volume>, <fpage>503</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001125</pub-id><pub-id pub-id-type="pmid">12082568</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knafo</surname><given-names>A.</given-names></name><name><surname>Israel</surname><given-names>S.</given-names></name><name><surname>Darvasi</surname><given-names>A.</given-names></name><name><surname>Bachner-Melman</surname><given-names>R.</given-names></name><name><surname>Uzefovsky</surname><given-names>F.</given-names></name><name><surname>Cohen</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Individual differences in allocation of funds in the dictator game associated with length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length and hippocampal mRNA</article-title>. <source/>Genes Brain Behav.
<volume>7</volume>, <fpage>266</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2007.00341.x</pub-id><pub-id pub-id-type="pmid">17696996</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosfeld</surname><given-names>M.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name><name><surname>Zak</surname><given-names>P. J.</given-names></name><name><surname>Fischbacher</surname><given-names>U.</given-names></name><name><surname>Fehr</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>Oxytocin increases trust in humans</article-title>. <source/>Nature
<volume>435</volume>, <fpage>673</fpage>–<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1038/nature03701</pub-id><pub-id pub-id-type="pmid">15931222</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreps</surname><given-names>D. M.</given-names></name><name><surname>Milgrom</surname><given-names>P.</given-names></name><name><surname>Roberts</surname><given-names>J.</given-names></name><name><surname>Wilson</surname><given-names>R.</given-names></name></person-group> (<year>1982</year>). <article-title>Rational cooperation in the finitely repeated prisoners-dilemma</article-title>. <source/>J. Econ. Theory
<volume>27</volume>, <fpage>245</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1016/0022-0531(82)90029-1</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krueger</surname><given-names>F.</given-names></name><name><surname>Parasuraman</surname><given-names>R.</given-names></name><name><surname>Iyengar</surname><given-names>V.</given-names></name><name><surname>Thornburg</surname><given-names>M.</given-names></name><name><surname>Weel</surname><given-names>J.</given-names></name><name><surname>Lin</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Oxytocin receptor genetic variation promotes human trust behavior</article-title>. <source/>Front. Hum. Neurosci.
<volume>6</volume>:<issue>4</issue>. <pub-id pub-id-type="doi">10.3389/fnhum.2012.00004</pub-id><pub-id pub-id-type="pmid">22347177</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuehn</surname><given-names>B. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Scientists probe oxytocin therapy for social deficits in autism, schizophrenia</article-title>. <source/>JAMA
<volume>305</volume>, <fpage>659</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2011.117</pub-id><pub-id pub-id-type="pmid">21325177</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labuschagne</surname><given-names>I.</given-names></name><name><surname>Phan</surname><given-names>K. L.</given-names></name><name><surname>Wood</surname><given-names>A.</given-names></name><name><surname>Angstadt</surname><given-names>M.</given-names></name><name><surname>Chua</surname><given-names>P.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder</article-title>. <source/>Neuropsychopharmacology
<volume>35</volume>, <fpage>2403</fpage>–<lpage>2413</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2010.123</pub-id><pub-id pub-id-type="pmid">20720535</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landgraf</surname><given-names>R.</given-names></name><name><surname>Neumann</surname><given-names>I. D.</given-names></name></person-group> (<year>2004</year>). <article-title>Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication</article-title>. <source/>Front. Neuroendocrinol.
<volume>25</volume>, <fpage>150</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.yfrne.2004.05.001</pub-id><pub-id pub-id-type="pmid">15589267</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leng</surname><given-names>G.</given-names></name><name><surname>Ludwig</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Neurotransmitters and peptides: whispered secrets and public announcements</article-title>. <source/>J. Physiol.
<volume>586(Pt 23)</volume>, <fpage>5625</fpage>–<lpage>5632</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2008.159103</pub-id><pub-id pub-id-type="pmid">18845614</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>R.</given-names></name><name><surname>Heresco-Levy</surname><given-names>U.</given-names></name><name><surname>Bachner-Melman</surname><given-names>R.</given-names></name><name><surname>Israel</surname><given-names>S.</given-names></name><name><surname>Shalev</surname><given-names>I.</given-names></name><name><surname>Ebstein</surname><given-names>R. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition</article-title>. <source/>Psychoneuroendocrinology
<volume>34</volume>, <fpage>901</fpage>–<lpage>908</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.12.014</pub-id><pub-id pub-id-type="pmid">19195791</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>C. M.</given-names></name><name><surname>Levinson</surname><given-names>D. F.</given-names></name><name><surname>Wise</surname><given-names>L. H.</given-names></name><name><surname>DeLisi</surname><given-names>L. E.</given-names></name><name><surname>Straub</surname><given-names>R. E.</given-names></name><name><surname>Hovatta</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia</article-title>. <source/>Am. J. Hum. Genet.
<volume>73</volume>, <fpage>34</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1086/376549</pub-id><pub-id pub-id-type="pmid">12802786</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y. C.</given-names></name><name><surname>Korol</surname><given-names>A. B.</given-names></name><name><surname>Fahima</surname><given-names>T.</given-names></name><name><surname>Nevo</surname><given-names>E.</given-names></name></person-group> (<year>2004</year>). <article-title>Microsatellites within genes: structure, function, and evolution</article-title>. <source/>Mol. Biol. Evol.
<volume>21</volume>, <fpage>991</fpage>–<lpage>1007</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msh073</pub-id><pub-id pub-id-type="pmid">14963101</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loup</surname><given-names>F.</given-names></name><name><surname>Tribollet</surname><given-names>E.</given-names></name><name><surname>Dubois-Dauphin</surname><given-names>M.</given-names></name><name><surname>Dreifuss</surname><given-names>J. J.</given-names></name></person-group> (<year>1991</year>). <article-title>Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain</article-title>. <source/>An autoradiographic study. Brain Res.
<volume>555</volume>, <fpage>220</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(91)90345-V</pub-id><pub-id pub-id-type="pmid">1657300</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ludwig</surname><given-names>M.</given-names></name><name><surname>Leng</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Dendritic peptide release and peptide-dependent behaviours</article-title>. <source/>Nat. Rev. Neurosci.
<volume>7</volume>, <fpage>126</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1845</pub-id><pub-id pub-id-type="pmid">16429122</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Rao</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>S.</given-names></name></person-group> (<year>2015a</year>). <article-title>Oxytocin receptor gene and racial ingroup bias in empathy-related brain activity</article-title>. <source/>Neuroimage
<volume>110</volume>, <fpage>22</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2015.01.042</pub-id><pub-id pub-id-type="pmid">25637390</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Shi</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2015b</year>). <article-title>Interaction between oxytocin receptor polymorphism and interdependent culture values on human empathy</article-title>. <source/>Soc. Cogn. Affect. Neurosci.
<pub-id pub-id-type="doi">10.1093/scan/nsv019</pub-id><pub-id pub-id-type="pmid">25680993</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luppino</surname><given-names>D.</given-names></name><name><surname>Moul</surname><given-names>C.</given-names></name><name><surname>Hawes</surname><given-names>D. J.</given-names></name><name><surname>Brennan</surname><given-names>J.</given-names></name><name><surname>Dadds</surname><given-names>M. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Association between a polymorphism of the vasopressin 1B receptor gene and aggression in children</article-title>. <source/>Psychiatr. Genet.
<volume>24</volume>, <fpage>185</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1097/ypg.0000000000000036</pub-id><pub-id pub-id-type="pmid">24842238</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>E.</given-names></name><name><surname>Dadds</surname><given-names>M. R.</given-names></name><name><surname>Brennan</surname><given-names>J. L.</given-names></name><name><surname>Williams</surname><given-names>K.</given-names></name><name><surname>Levy</surname><given-names>F.</given-names></name><name><surname>Cauchi</surname><given-names>A. J.</given-names></name></person-group> (<year>2011</year>). <article-title>A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research</article-title>. <source/>Psychoneuroendocrinology
<volume>36</volume>, <fpage>1114</fpage>–<lpage>1126</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2011.02.015</pub-id><pub-id pub-id-type="pmid">21429671</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>K.</given-names></name><name><surname>Feifel</surname><given-names>D.</given-names></name></person-group> (<year>2012</year>). <article-title>Oxytocin in schizophrenia: a review of evidence for its therapeutic effects</article-title>. <source/>Acta Neuropsychiatr.
<volume>24</volume>, <fpage>130</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-5215.2011.00634.x</pub-id><pub-id pub-id-type="pmid">22736892</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>K.</given-names></name><name><surname>Macdonald</surname><given-names>T. M.</given-names></name></person-group> (<year>2010</year>). <article-title>The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans</article-title>. <source/>Harv. Rev. Psychiatry
<volume>18</volume>, <fpage>1</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3109/10673220903523615</pub-id><pub-id pub-id-type="pmid">20047458</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuffin</surname><given-names>P.</given-names></name><name><surname>Katz</surname><given-names>R.</given-names></name></person-group> (<year>1989</year>). <article-title>The genetics of depression and manic-depressive disorder</article-title>. <source/>Br. J. Psychatr.
<volume>155</volume>, <fpage>294</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1192/bjp.155.3.294</pub-id><pub-id pub-id-type="pmid">2692760</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuffin</surname><given-names>P.</given-names></name><name><surname>Rijsdijk</surname><given-names>F.</given-names></name><name><surname>Andrew</surname><given-names>M.</given-names></name><name><surname>Sham</surname><given-names>P.</given-names></name><name><surname>Katz</surname><given-names>R.</given-names></name><name><surname>Cardno</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>The heritability of bipolar affective disorder and the genetic relationship to unipolar depression</article-title>. <source/>Arch. Gen. Psychiatry
<volume>60</volume>, <fpage>497</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.60.5.497</pub-id><pub-id pub-id-type="pmid">12742871</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuaid</surname><given-names>R. J.</given-names></name><name><surname>McInnis</surname><given-names>O. A.</given-names></name><name><surname>Matheson</surname><given-names>K.</given-names></name><name><surname>Anisman</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Distress of ostracism: oxytocin receptor gene polymorphism confers sensitivity to social exclusion</article-title>. <source/>Soc. Cogn. Affect. Neurosci. <volume>10</volume>, <fpage>1153</fpage>–<lpage>1159</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nsu166</pub-id><pub-id pub-id-type="pmid">25564674</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuaid</surname><given-names>R. J.</given-names></name><name><surname>McInnis</surname><given-names>O. A.</given-names></name><name><surname>Stead</surname><given-names>J. D.</given-names></name><name><surname>Matheson</surname><given-names>K.</given-names></name><name><surname>Anisman</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>A paradoxical association of an oxytocin receptor gene polymorphism: early-life adversity and vulnerability to depression</article-title>. <source/>Front. Neurosci.
<volume>7</volume>:<issue>128</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2013.00128</pub-id><pub-id pub-id-type="pmid">23898235</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendlewicz</surname><given-names>J.</given-names></name><name><surname>Crisafulli</surname><given-names>C.</given-names></name><name><surname>Calati</surname><given-names>R.</given-names></name><name><surname>Kocabas</surname><given-names>N.</given-names></name><name><surname>Massat</surname><given-names>I.</given-names></name><name><surname>Linotte</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression</article-title>. <source/>Neurosci Lett.
<volume>516</volume>, <fpage>85</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2012.03.063</pub-id><pub-id pub-id-type="pmid">22487732</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name><name><surname>Domes</surname><given-names>G.</given-names></name><name><surname>Kirsch</surname><given-names>P.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine</article-title>. <source/>Nat. Rev. Neurosci.
<volume>12</volume>, <fpage>524</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3044</pub-id><pub-id pub-id-type="pmid">21852800</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name><name><surname>Kolachana</surname><given-names>B.</given-names></name><name><surname>Gold</surname><given-names>B.</given-names></name><name><surname>Olsh</surname><given-names>A.</given-names></name><name><surname>Nicodemus</surname><given-names>K. K.</given-names></name><name><surname>Mattay</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans</article-title>. <source/>Mol. Psychiatry
<volume>14</volume>, <fpage>968</fpage>–<lpage>975</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.54</pub-id><pub-id pub-id-type="pmid">18490926</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moons</surname><given-names>W. G.</given-names></name><name><surname>Way</surname><given-names>B. M.</given-names></name><name><surname>Taylor</surname><given-names>S. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin and vasopressin receptor polymorphisms interact with circulating neuropeptides to predict human emotional reactions to stress</article-title>. <source/>Emotion
<volume>14</volume>, <fpage>562</fpage>–<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1037/a0035503</pub-id><pub-id pub-id-type="pmid">24660771</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>M.</given-names></name><name><surname>Görlich</surname><given-names>A.</given-names></name><name><surname>Heintz</surname><given-names>N.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin modulates female sociosexual behavior through a specific class of prefrontal cortical interneurons</article-title>. <source/>Cell
<volume>159</volume>, <fpage>295</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.020</pub-id><pub-id pub-id-type="pmid">25303526</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>I. D.</given-names></name><name><surname>Landgraf</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors</article-title>. <source/>Trends Neurosci.
<volume>35</volume>, <fpage>649</fpage>–<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2012.08.004</pub-id><pub-id pub-id-type="pmid">22974560</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyffeler</surname><given-names>J.</given-names></name><name><surname>Walitza</surname><given-names>S.</given-names></name><name><surname>Bobrowski</surname><given-names>E.</given-names></name><name><surname>Gundelfinger</surname><given-names>R.</given-names></name><name><surname>Grünblatt</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism</article-title>. <source/>J. Mol. Psychiatry
<volume>2</volume>, <fpage>1</fpage>. <pub-id pub-id-type="doi">10.1186/2049-9256-2-1</pub-id><pub-id pub-id-type="pmid">25408912</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozsoy</surname><given-names>S.</given-names></name><name><surname>Esel</surname><given-names>E.</given-names></name><name><surname>Kula</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment</article-title>. <source/>Psychiatry Res.
<volume>169</volume>, <fpage>249</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2008.06.034</pub-id><pub-id pub-id-type="pmid">19732960</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitman</surname><given-names>R. K.</given-names></name><name><surname>Orr</surname><given-names>S. P.</given-names></name><name><surname>Lasko</surname><given-names>N. B.</given-names></name></person-group> (<year>1993</year>). <article-title>Effects of intranasal vasopressin and oxytocin on physiologic responding during personal combat imagery in Vietnam veterans with posttraumatic stress disorder</article-title>. <source/>Psychiatry Res.
<volume>48</volume>, <fpage>107</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/0165-1781(93)90035-F</pub-id><pub-id pub-id-type="pmid">8416021</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Plomin</surname><given-names>R.</given-names></name><name><surname>DeFries</surname><given-names>J. C.</given-names></name><name><surname>Knopik</surname><given-names>V. S.</given-names></name><name><surname>Neiderhiser</surname><given-names>J. M.</given-names></name></person-group> (<year>2008</year>). <source/>Behavioral Genetics, 5th Edn.
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Worth Publishers</publisher-name>.</mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>S. B.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Geyer</surname><given-names>M. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Prepulse inhibition and genetic mouse models of schizophrenia</article-title>. <source/>Brain
<volume>204</volume>, <fpage>282</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2009.04.021</pub-id><pub-id pub-id-type="pmid">19397931</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabin</surname><given-names>M.</given-names></name></person-group> (<year>1993</year>). <article-title>Incorporating fairness into game theory and economics</article-title>. <source/>Am. Econ. Rev.
<volume>83</volume>, <fpage>1281</fpage>–<lpage>1302</lpage>.</mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radke</surname><given-names>S.</given-names></name><name><surname>de Bruijn</surname><given-names>R. A.</given-names></name></person-group> (<year>2012</year>). <article-title>The other side of the coin: oxytocin decreases the adherence to fairness norms</article-title>. <source/>Front. Hum. Neurosci.
<volume>6</volume>:<issue>193</issue>. <pub-id pub-id-type="doi">10.3389/fnhum.2012.00193</pub-id><pub-id pub-id-type="pmid">22754520</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratajczak</surname><given-names>P.</given-names></name><name><surname>WoŸniak</surname><given-names>A.</given-names></name><name><surname>Nowakowska</surname><given-names>E.</given-names></name></person-group> (<year>2013</year>). <article-title>Animal models of schizophrenia: developmental preparation in rats</article-title>. <source/>Acta Neurobiol. Exp.
<volume>73</volume>, <fpage>472</fpage>–<lpage>484</lpage>. <pub-id pub-id-type="pmid">24457639</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiner</surname><given-names>I.</given-names></name><name><surname>Van IJzendoorn</surname><given-names>M. H.</given-names></name><name><surname>Bakermans-Kranenburg</surname><given-names>M. J.</given-names></name><name><surname>Bleich</surname><given-names>S.</given-names></name><name><surname>Beutel</surname><given-names>M.</given-names></name><name><surname>Frieling</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Methylation of the oxytocin receptor gene in clinically depressed patients compared to controls: the role of OXTR rs53576 genotype</article-title>. <source/>J. Psychiatr. Res.
<volume>65</volume>, <fpage>9</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2015.03.012</pub-id><pub-id pub-id-type="pmid">25890851</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Risch</surname><given-names>N. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Searching for genetic determinants in the new millennium</article-title>. <source/>Nature
<volume>405</volume>, <fpage>847</fpage>–<lpage>856</lpage>. <pub-id pub-id-type="doi">10.1038/35015718</pub-id><pub-id pub-id-type="pmid">10866211</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>S. M.</given-names></name><name><surname>Saslow</surname><given-names>L. R.</given-names></name><name><surname>Garcia</surname><given-names>N.</given-names></name><name><surname>John</surname><given-names>O. P.</given-names></name><name><surname>Keltner</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>106</volume>, <fpage>21437</fpage>–<lpage>21441</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909579106</pub-id><pub-id pub-id-type="pmid">19934046</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sala</surname><given-names>M.</given-names></name><name><surname>Braida</surname><given-names>D.</given-names></name><name><surname>Lentini</surname><given-names>D.</given-names></name><name><surname>Busnelli</surname><given-names>M.</given-names></name><name><surname>Bulgheroni</surname><given-names>E.</given-names></name><name><surname>Capurro</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism</article-title>. <source/>Biol. Psychiatry
<volume>69</volume>, <fpage>875</fpage>–<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.12.022</pub-id><pub-id pub-id-type="pmid">21306704</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname><given-names>C.</given-names></name><name><surname>Montag</surname><given-names>C.</given-names></name><name><surname>Reuter</surname><given-names>M.</given-names></name><name><surname>Kirsch</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Imaging oxytocin x dopamine interactions: an epistasis effect of CD38 and COMT gene variants influences the impact of oxytocin on amygdala activation to social stimuli</article-title>. <source/>Front. Neurosci.
<volume>7</volume>:<issue>45</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2013.00045</pub-id><pub-id pub-id-type="pmid">23554586</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seibold</surname><given-names>A.</given-names></name><name><surname>Brabet</surname><given-names>P.</given-names></name><name><surname>Rosenthal</surname><given-names>W.</given-names></name><name><surname>Birnbaumer</surname><given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>Structure and chromosomal localization of the human antidiuretic hormone receptor gene</article-title>. <source/>Am. J. Hum. Genet.
<volume>51</volume>, <fpage>1078</fpage>–<lpage>1083</lpage>. <pub-id pub-id-type="pmid">1415251</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamay-Tsoory</surname><given-names>S. G.</given-names></name><name><surname>Aharon-Peretz</surname><given-names>J.</given-names></name><name><surname>Perry</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Two systems for empathy: a double dissociation between emotional and cognitive empathy in inferior frontal gyrus versus ventromedial prefrontal lesions</article-title>. <source/>Brain
<volume>132</volume>, <fpage>617</fpage>–<lpage>627</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awn279</pub-id><pub-id pub-id-type="pmid">18971202</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoop</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Neuromodulation by oxytocin and vasopressin</article-title>. <source/>Neuron
<volume>76</volume>, <fpage>142</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.09.025</pub-id><pub-id pub-id-type="pmid">23040812</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname><given-names>T.</given-names></name><name><surname>Saito</surname><given-names>M.</given-names></name><name><surname>Mochizuki</surname><given-names>S.</given-names></name><name><surname>Watanabe</surname><given-names>Y.</given-names></name><name><surname>Hashimoto</surname><given-names>S.</given-names></name><name><surname>Kawashima</surname><given-names>H.</given-names></name></person-group> (<year>1994</year>). <article-title>Molecular cloning and functional expression of a cDNA encoding the human v1b vasopressin receptor</article-title>. <source/>J. Biol. Chem.
<volume>269</volume>, <fpage>27088</fpage>–<lpage>27092</lpage>. <pub-id pub-id-type="pmid">7929452</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tachibana</surname><given-names>M.</given-names></name><name><surname>Kagitani-Shimono</surname><given-names>K.</given-names></name><name><surname>Mohri</surname><given-names>I.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Sanefuji</surname><given-names>W.</given-names></name><name><surname>Nakamura</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders</article-title>. <source/>J. Child Adolesc. Psychopharmacol.
<volume>23</volume>, <fpage>123</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1089/cap.2012.0048</pub-id><pub-id pub-id-type="pmid">23480321</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tansey</surname><given-names>K. E.</given-names></name><name><surname>Hill</surname><given-names>M. J.</given-names></name><name><surname>Cochrane</surname><given-names>L. E.</given-names></name><name><surname>Gill</surname><given-names>M.</given-names></name><name><surname>Anney</surname><given-names>R. J.</given-names></name><name><surname>Gallagher</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Functionality of promoter microsatellites of arginine vasopressin receptor 1A (AVPR1A): implications for autism</article-title>. <source/>Mol. Autism
<volume>2</volume>, <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-2-3</pub-id><pub-id pub-id-type="pmid">21453499</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibonnier</surname><given-names>M.</given-names></name></person-group> (<year>1992</year>). <article-title>Signal transduction of V1-vascular vasopressin receptors</article-title>. <source/>Regul. Pept.
<volume>38</volume>, <fpage>1</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/0167-0115(92)90067-5</pub-id><pub-id pub-id-type="pmid">1533467</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibonnier</surname><given-names>M.</given-names></name><name><surname>Graves</surname><given-names>M. K.</given-names></name><name><surname>Wagner</surname><given-names>M. S.</given-names></name><name><surname>Auzan</surname><given-names>C.</given-names></name><name><surname>Clauser</surname><given-names>E.</given-names></name><name><surname>Willard</surname><given-names>H. F.</given-names></name></person-group> (<year>1996</year>). <article-title>Structure, sequence, expression, and chromosomal localization of the human V1a vasopressin receptor gene</article-title>. <source/>Genomics
<volume>31</volume>, <fpage>327</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1996.0055</pub-id><pub-id pub-id-type="pmid">8838314</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibonnier</surname><given-names>M.</given-names></name><name><surname>Graves</surname><given-names>M. K.</given-names></name><name><surname>Wagner</surname><given-names>M. S.</given-names></name><name><surname>Chatelain</surname><given-names>N.</given-names></name><name><surname>Soubrier</surname><given-names>F.</given-names></name><name><surname>Corvol</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>32</volume>, <fpage>557</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.2000.1108</pub-id><pub-id pub-id-type="pmid">10756113</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thibonnier</surname><given-names>M.</given-names></name><name><surname>Schork</surname><given-names>N. J.</given-names></name></person-group> (<year>1995</year>). <article-title>The genetics of hypertension</article-title>. <source/>Curr. Opin. Genet. Dev.
<volume>5</volume>, <fpage>362</fpage>–<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1016/0959-437X(95)80052-2</pub-id><pub-id pub-id-type="pmid">7549432</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>R. G.</given-names></name><name><surname>Holman</surname><given-names>E. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Environmental stress, oxytocin receptor gene (OXTR) polymorphism, and mental health following collective stress</article-title>. <source/>Horm. Behav.
<volume>63</volume>, <fpage>615</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2013.02.015</pub-id><pub-id pub-id-type="pmid">23470776</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>R. J.</given-names></name><name><surname>Parker</surname><given-names>K. J.</given-names></name><name><surname>Hallmayer</surname><given-names>J. F.</given-names></name><name><surname>Waugh</surname><given-names>C. E.</given-names></name><name><surname>Gotlib</surname><given-names>I. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls</article-title>. <source/>Psychoneuroendocrinology
<volume>36</volume>, <fpage>144</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2010.07.003</pub-id><pub-id pub-id-type="pmid">20708845</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>S. M.</given-names></name><name><surname>Hammen</surname><given-names>C.</given-names></name><name><surname>Starr</surname><given-names>L. R.</given-names></name><name><surname>Najman</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxytocin receptor gene polymorphism (rs53576) moderates the intergenerational transmission of depression</article-title>. <source/>Psychoneuroendocrinology
<volume>43</volume>, <fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.01.012</pub-id><pub-id pub-id-type="pmid">24703166</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van West</surname><given-names>D.</given-names></name><name><surname>Del-Favero</surname><given-names>J.</given-names></name><name><surname>Aulchenko</surname><given-names>Y.</given-names></name><name><surname>Oswald</surname><given-names>P.</given-names></name><name><surname>Souery</surname><given-names>D.</given-names></name><name><surname>Forsgren</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>A major SNP haplotype of the arginine vasopressin 1B receptor protects against recurrent major depression</article-title>. <source/>Mol. Psychiatry
<volume>9</volume>, <fpage>287</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001420</pub-id><pub-id pub-id-type="pmid">15094789</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veening</surname><given-names>J. G.</given-names></name><name><surname>Olivier</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Intranasal administration of oxytocin: behavioral and clinical effects, a review</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>37</volume>, <fpage>1445</fpage>–<lpage>1465</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2013.04.012</pub-id><pub-id pub-id-type="pmid">23648680</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Huntington's disease</article-title>. <source/>Lancet
<volume>369</volume>, <fpage>218</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60111-1</pub-id><pub-id pub-id-type="pmid">17240289</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Qin</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Neural mechanisms of oxytocin receptor gene mediating anxiety-related temperament</article-title>. <source/>Brain Struct Funct. <volume>219</volume>, <fpage>1543</fpage>–<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.1007/s00429-013-0584-9</pub-id><pub-id pub-id-type="pmid">23708061</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>K. D.</given-names></name><name><surname>Cheung</surname><given-names>C. K. T.</given-names></name><name><surname>Choi</surname><given-names>W.</given-names></name></person-group> (<year>2000</year>). <article-title>Cyberostracism: effects of being ignored over the Internet</article-title>. <source/>J. Pers. Soc. Psychol.
<volume>79</volume>, <fpage>748</fpage>–<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1037/0022-3514.79.5.748</pub-id><pub-id pub-id-type="pmid">11079239</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Su</surname><given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>The association between oxytocin receptor gene polymorphism (OXTR) and trait empathy</article-title>. <source/>J. Affect. Disord.
<volume>138</volume>, <fpage>468</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2012.01.009</pub-id><pub-id pub-id-type="pmid">22357335</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Jia</surname><given-names>M.</given-names></name><name><surname>Ruan</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name><name><surname>Shuang</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population</article-title>. <source/>Biol. Psychiatry
<volume>58</volume>, <fpage>74</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.03.013</pub-id><pub-id pub-id-type="pmid">15992526</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y. L.</given-names></name><name><surname>Su</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>S. X.</given-names></name><name><surname>Liu</surname><given-names>A. J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Effect of oxytocin on the behavioral activity in the behavioral despair depression rat model</article-title>. <source/>Neuropeptides
<volume>48</volume>, <fpage>83</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.npep.2014.01.001</pub-id><pub-id pub-id-type="pmid">24444823</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yirmiya</surname><given-names>N.</given-names></name><name><surname>Rosenberg</surname><given-names>C.</given-names></name><name><surname>Levi</surname><given-names>S.</given-names></name><name><surname>Salomon</surname><given-names>S.</given-names></name><name><surname>Shulman</surname><given-names>C.</given-names></name><name><surname>Nemanov</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills</article-title>. <source/>Mol. Psychiatry
<volume>11</volume>, <fpage>488</fpage>–<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001812</pub-id><pub-id pub-id-type="pmid">16520824</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>L.</given-names></name><name><surname>Nilsen</surname><given-names>R.</given-names></name><name><surname>Waymire</surname><given-names>K.</given-names></name><name><surname>MacGregor</surname><given-names>G.</given-names></name></person-group> (<year>1999</year>). <article-title>Increased affillative response to vasopressin in mice expressing the V1a receptor from a monogamous vole</article-title>. <source/>Nature
<volume>400</volume>, <fpage>1998</fpage>–<lpage>2000</lpage>. <pub-id pub-id-type="doi">10.1038/23650</pub-id><pub-id pub-id-type="pmid">10466725</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zai</surname><given-names>C. C.</given-names></name><name><surname>Muir</surname><given-names>K. E.</given-names></name><name><surname>Nowrouzi</surname><given-names>B.</given-names></name><name><surname>Shaikh</surname><given-names>S. A.</given-names></name><name><surname>Choi</surname><given-names>E.</given-names></name><name><surname>Berall</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Possible genetic association between vasopressin receptor 1B and child aggression</article-title>. <source/>Psychiatry Res.
<volume>200</volume>, <fpage>784</fpage>–<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2012.07.031</pub-id><pub-id pub-id-type="pmid">22910476</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zak</surname><given-names>P. J.</given-names></name><name><surname>Stanton</surname><given-names>A. A.</given-names></name><name><surname>Ahmadi</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Oxytocin increases generosity in humans</article-title>. <source/>PLoS ONE
<volume>2</volume>:<fpage>e1128</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0001128</pub-id><pub-id pub-id-type="pmid">17987115</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zink</surname><given-names>C. F.</given-names></name><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Human neuroimaging of oxytocin and vasopressin in social cognition</article-title>. <source/>Horm. Behav.
<volume>61</volume>, <fpage>400</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2012.01.016</pub-id><pub-id pub-id-type="pmid">22326707</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>